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An increasing body of research is suggesting that childhood trauma and adversity 
may be associated with various adverse mental health outcomes, including 
psychosis. Cognitive functioning is often compromised in psychosis, and research 
has shown that there may be a link between early trauma and cognitive impairment 
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in people with psychosis. No systematic review of the literature of this link has been 
undertaken, and very few studies have examined samples of individuals at high 
clinical risk for psychosis, to assess whether the potential link between adversity 
and cognitive functioning exists, without the confounding factors of length of 




The systematic review of all relevant electronic databases investigates the research 
to date on the association between childhood adverse experiences and cognitive 
ability in psychosis, and the conclusions that can be drawn from the existing 
literature, taking into account relevant considerations regarding sample, 
methodology and statistical analysis. The subsequent empirical study utilizes a 
sample at clinical high risk of developing psychosis, and a healthy control group to 
investigate whether any putative association in specific domains of cognitive 
functioning, or global cognitive ability and childhood adversity exist in those at 




The systematic review indicated that at present, the literature looking into 
childhood adversity and cognitive ability in relation to psychosis is heterogeneous, 
with some studies finding that this association only occurs in patients, whilst others 
suggest it only occurs in the control groups. Some studies found it to be specific to 
certain cognitive domains, whilst others suggest it was a more global impairment. 
Methodology, samples and analysis differed considerably across studies, and likely 
contribute to the heterogeneity of the literature. The empirical paper showed a 
significant interaction effect between group (high risk versus controls) in the high 
childhood adversity group, in relation to global cognitive ability. Interestingly, this 
was not related to psychotic symptom severity or distress. 






Several limitations of the existing studies limit the conclusions that can be drawn 
from the existing evidence regarding the link between childhood adversity and 
cognitive ability, and future research in prodromal samples is essential. The 
empirical study showed that there is a link between childhood adversity and 
cognitive ability in those at clinical high risk of developing psychosis, before disorder 
onset, that is not present in controls. This suggests that this may form a 
vulnerability in those at high risk for psychosis, rather than a more general 












Thesis Lay Summary 
 
Background: Researchers have found that early traumatic experiences and stress 
may increase somebody’s risk of developing psychosis. However, the mechanisms 
underlying this association are still unclear. Some investigators have suggested that 
early trauma may impact normal brain development negatively by affecting systems 
involved in generating our stress response, and psychological mechanisms involved 
in generating psychotic symptoms. It is unclear at present to what extent early 
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adversity and brain development interact in this way, and whether people that are 
at high risk of developing psychosis may also show these signs of altered brain 
development, or whether it only occurs in people that have had established 
psychosis for a long time. 
 
Method: This portfolio has involved reviewing the existing literature using 
systematic review techniques to comprehensively assess the link between 
childhood adversity and mental abilities, such as memory and global estimates of 
mental ability, in relation to psychosis. These techniques involved searching 8 
different databases and critically assessing them using narrative synthesis 
techniques. We then also looked at this link in people at high clinical risk of 
developing psychosis, in order to see if this link between trauma and cognitive 
ability was present in people at high risk of developing psychosis, but before 
disorder onset. This would reduce the risk of thepresence of confounding factors 
such as length of illness. 
 
Results: We found that across the existing literature, there were so many different 
samples, methods, and statistics used that it is difficult to interpret any of the 
literature with real clarity. We found that people at clinical high risk may be 
particularly sensitive to the effects of high levels of trauma compared to healthy 
controls. 
  
Conclusions: The systematic review found that more research into the link between 
childhood adversity and brain development is required, taking into account other 
relevant factors, such as duration of illness and medication. The experimental study 
reported here demonstrates that there may be some changes in global mental 
ability in people at high risk of developing psychosis due to elevated clinical 
symptoms that does not occur in those people that do not have these difficulties. 
Therefore there may be changes to brain development and psychological 
mechanisms in those at high risk in relation to early adversity.  
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Systematic Review Abstract: 
 
Background 
An increasing body of research is suggesting that childhood trauma may be 
associated with psychosis. Cognitive functioning is often compromised in psychosis, 
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and research has shown that a link between early childhood trauma and cognitive 
functioning in people with psychosis may exist. 
 
Method 
The aim of this study is to provide a narrative systematic review of the research 
literature on all articles published in English that investigated the association 
between cognitive function and childhood trauma or adverse childhood experiences 
in individuals with psychosis. In total, eight databases were searched. Additional 
articles were identified following examination of reference lists from primary search 
results to ensure that all pertinent studies were included. Categories of search 
terms covering psychosis, childhood trauma/adversity and cognitive ability within 
databases was implemented where possible to ensure a comprehensive search of 
the available literature. 
 
Results 
Electronic database searches yielded 1051 results with 814 remaining following the 
exclusion of duplicates and a total of 18 meeting our criteria were included for the 
study. Some studies identified associations between cognitive ability and trauma,  
however studies varied in the cognitive domains in which associations between 
cognitive ability and trauma were found, and whether these occurred only in the 
patient groups, or also/only in the control groups.  
r.   
Conclusions 
The review highlights the need for larger studies with individuals presenting with 
first episode psychosis or high-risk samples, and the need for more homogenous 
conceptualisations of childhood trauma/adversity and cognitive ability to be used 
across studies in order to provide more robust interpretability and generalisability. 
Reviewed papers highlighted the heterogeneity of participants and differing 
methodology, which limit the generalizability of findings.  
 


















1. Introduction  
1.1 Introduction 
An accumulating body of evidence is converging to suggest that an association 
exists between childhood trauma (CT) and psychotic disorders, such as 
schizophrenia.1-4 Rates of self-reported CT are higher in individuals with psychotic 
disorders5,6 compared to the typical population7,8 and a recent meta-analysis 
concluded that even the broader definition encompassing adverse childhood 
experiences (ACEs), such as bullying by peers, parental separation and witnessing 
domestic abuse, strongly contribute to the risk of psychosis in adulthood, with a 
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cumulative dose/response relationship between number of events experienced and 
the likelihood of psychotic symptoms.9  
 
Evidence also suggests that psychosis, and in particular schizophrenia, are related to 
severe cognitive impairments compared to healthy controls10,11 , spanning several 
different cognitive domains, such as executive, working memory, sustained 
attention, episodic and verbal memory, as well as global impairments in cognition12-
16. These have been associated with level of disability17 occupational impairments, 
functional outcome17-21 and severity of positive symptoms 22-25. It has been 
suggested that CT/ACE may be associated with these impairments, by having 
adverse effects on the neural systems that are critical to responding to stress, such 
as the hypothalamic-pituitary-adrenal (HPA) and noradrenergic systems26-29. This 
may then contribute to the structural and functional brain changes that have been 
implicated in the pathophysiology of psychosis, such as reduced hippocampal 
volumes and cortical thinning30-35.  
 
Furthermore, psychological models of psychosis suggest that early ACEs contribute 
to the emergence of symptoms by triggering a change in arousal mechanisms, such 
as heightened anxiety, which, in the context of vulnerability to psychosis, may 
create a cognitive confusion causing an anomalous experience, such as thoughts 
being experienced as voices. These subtle cognitive changes may then trigger the 
cognitive abnormalities associated with psychosis, as well as be linked to specific 
psychotic symptoms. This model proposits that specific psychotic symptoms, such 
as persecutory delusions,  may arise from a search for meaning that reflects an 
interaction between psychotic processes, pre-existing beliefs and the adverse 
environment36-37 
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 Although the evidence suggests ACEs and the putatively affected processes may 
underpin the cognitive deficits in psychosis38, to date, there is inconsistency to what 
extent cognitive impairments are associated with early adversity, and if so which 
cognitive domains are most affected, or whether the deficits present on a more 
global cognitive scale. Some studies also show that early adversity may have a 
detrimental effect on cognitive ability in the typical population too, in the absence 
of mental health issues, and thus it remains unclear whether CT lies on the 
aetiological pathway to psychosis by impacting on cognitive ability, or whether it is 
a more general mechanism present in the typical population as well39-40. 
Understanding the way in which adversity associates with cognitive function may 
have crucial implications for the way in which therapy is delivered for individuals 
with psychosis. Currently cognitive behavioural therapy for psychosis is 
recommended as a treatment option, which should be made available to everyone 
with a diagnosis of schizophrenia in England and Wales and Scotland 41-43. However, 
if adversity affects cognitive ability, this may warrant a trauma-focused 
psychological treatment, which in itself may need to be revised or adapted in the 
context of impaired cognitive ability. Additionally, as early intervention in psychosis 
is associated with improved prognosis44, understanding the way in which 
CT/adversity and cognitive ability is associated in psychosis, compared to the typical 
population may also provide a target for early intervention strategies. 
 
Some of the inconsistencies may stem from cross-study variability in the quality of 
cognitive testing, differences in trauma measures, sample sizes, definition of 
patients and inclusion of controls.  To our knowledge, no systematic review of this 
literature exists. Hence, the aim of this systematic review is to synthesize and assess 
the current evidence base that has investigated CT and how it associates with 
cognitive function in relation to psychosis, and to identify gaps and areas for further 
research. The terms CT and ACE will be used interchangeably across this systematic 
review, unless otherwise stated, as they are often used interchangeably across the 
literature. As a secondary aim, we wish to assess whether the evidence suggests 
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1.2.1 Search Strategy and Inclusion Criteria 
 
An inclusive search strategy spanning all relevant databases was implemented 
(Appendix B). Subsequently, papers were included in the review if they met the 
following criteria 
 They were peer reviewed original empirical work (ie not book chapters, 
conference abstracts, reviews) published in English 
 A measure of cognitive ability using a known, standardized test was 
employed  
 Paper must have examined the association between trauma and cognitive 
ability in their sample  
 A sample of individuals presenting with psychosis were included 
 Studies measuring CT/ACEs, defined as: (1) must have occurred before age 
18 or be described as in “childhood” or “adolescence” (2) must be 
differentiated from adulthood trauma 
 
A subsample of papers were at this stage also screened by an independent rater to 
minimize bias in selection of reviewed studies. Categories covering psychosis and 
cognitive ability within databases was implemented where possible to ensure a 
comprehensive search of the available literature, and identified using the following 
search terms “cognitive ability*” or cognition or neuropsychol* or “neuro* 
assessment*” or “cognitive assess*” AND  (pathway* or associat* or or 
“mechanism*” mediat* or variable* or relation* or "risk *", “predictor”) AND “child 
abus*” “child traum*” “physical abus*” “sexual abus*” “rape*”  “psychological 
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abus*” “emotional abus*” “neglect*” “maltreat*” “bully” “bullied” “victim*” 
“sexual trauma*” “psychological traum*” “physical assault*” “sexual assault*” 
“molest*”   AND (psychos* or schiz* or hallucinat* or paranoi* or voice* or 
delusion* or prodrom* OR  high risk).“psychological distress”  
  
Databases searched were Pubmed/Medline, PsychArticles full text, EMBASE, 
EMBASE classic, Global Health, Epub ahead of print and other non-indexed citations. 
Web of Science and Proquest were also searched to see if any further articles 
emerged, however they did not. Additional articles were identified following 
examination of reference lists from primary search results to ensure, as much as 
possible, that all pertinent studies were included.  
 
 
1.2.2 Data Extraction 
Where available, the following data were extracted from each included article: 
authors, year of publication, sample characteristics (sample type/source, sample 
size, age, sex, recruitment source, country), cognitive variables, and trauma 
measure used, inclusion and exclusion criteria of participants and findings 
pertaining to the relationship between cognitive ability and CT.  
 
1.2.3 Quality Assessment 
As most published quality criteria checklists relate to randomised controlled trials 
and intervention studies, which this systematic review does not contain, new 
quality criteria were developed and adapted from existing sources. Fourteen quality 
criteria were developed (Appendix C) after consultation with colleagues: COSMIN 
checklist, CONSORT checklist, SIGN methodology checklists, CASP critical appraisal 
checklists and PRISMA statement45-49. These fourteen quality criteria guided the 
subsequent quality appraisal. A random sample of studies was reviewed by one 
other reviewer to increase the validity of the ratings.  All disagreements were 
resolved by discussion between the tworeviewers.    The independent reviewer, a 
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third-year Trainee Clinical Psychologist, applied the quality assessment to six 
papers, as a check of reliability. Cohen’s κ suggested substantial agreement in 
ratings, κ=.88, p<.001. All initial disagreements were discussed and resolved 





1.3.1 Papers included for Review 
The process of identifying studies for inclusion is presented graphically in Figure 1.  
 
 
Figure 1.  Search results and selection procedure illustrated in a PRISMA flowchart47 
 
Electronic database searches yielded 1051 results with 814 remaining following the 
exclusion of duplicates.  The first screening wave consisted of reviewing titles only, 
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and this resulted in the exclusion of 419 titles. The second wave involved reviewing 
abstracts too, and this excluded a further 177 references. At this point 43 papers 
were reviewed in more depth, and at this stage 22 further studies were excluded as 
they did not meet the criteria of either being primary research, no measure of 
psychotic symptomology, no measure of trauma and/or cognition. A further 2 
studies were found by hand searching the reference lists at this stage. A Total of 18 
included for the study. 
 
1.3.2 Critical appraisal of study quality 
 
In general, most studies found that there were associations between CT and cognitive 
ability, in that higher levels of abuse was associated with lower levels of cognitive 
functioning. However, the quality of the reviewed papers was in general confounded 
by poor generalizability and inadequate statistical sampling. All studies clearly set out 
their objectives for their investigations; namely, to investigate the link between CT/ACE and 
cognitive ability. However, some studies provided only partial rationale regarding why they 
focused on specific types of CT such as sexual abuse, or why they focused their 
investigation on the cognitive domains that they did50-54. This creates potential for bias in 
the literature by an inadequate sampling of all types of CT/ACE and cognitive ability. For a 
summary of extracted demographic variables, please see Appendix E. For the 
quality ratings of each reviewed paper please see Appendix F.  
 
.  
1.3.4 Methodology of reviewed papers  
 
1.3.4.1 Sample size and inclusion/exclusion criteria considerations 
 
 The reviewed studies vary considerably in their sampling methods, setting, age 
range, gender, and to what extent they adequately capture a representative sample 
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of the target population. Sample sizes ranged from as small as forty with no control 
group54, to over 1000 with an inclusion of an adequate control group55. Only one 
study used a prospective power analysis to establish an appropriate sample size56. 
Interestingly, the one other study54 that conducted a posteriori power concluded 
that their sample size of 134 patients, and 124 controls was inadequate to detect 
previously found associations between CT and cognitive domains tested. This has 
implications for the studies that were reviewed that included smaller samples than 
this50-52, 57-59, and sheds doubt on the extent to which the reviewed papers utilize 
sample sizes large enough to capture the association between CT and cognitive 
ability, in particular if not reporting effect sizes for any resulting associations.  
 
Variation also existed in the specifics of the inclusion and exclusion criteria for the 
targeted populations for each study (For a detailed summary of these in relation to 
each study, please see appendix E). This creates difficulty in replication, as well as 
limiting generalisability across studies. For example, one study60 cited unstable 
medical conditions as an exclusion criterion, providing no further information 
regarding what these conditions were. Three studies failed to mention any 
exclusion criteria49, 50,52. Most studies also varied in the cut-off criteria for full scale 
IQ, meaning that some studies did not exclude based on intellectual disability or 
provided different values for their cut-off for included individual studies, which 
limits cross-study generalisability as well as obscuring interpretability of any 
putative associations between cognitive ability and CT/ACE in these studies. 
 
1.3.4.2 Recruitment setting considerations 
Recruitment settings ranged across studies, including inpatient, outpatient, 
community centre and local support groups. Some of the reviewed studies recruited 
patients from only one setting50,51, 61 , 54   whilst others had a mix of inpatient and 
outpatient settings,52,55,60,61-63,58, . Including both inpatient and outpatient samples is 
a strength in the sense that it targets a broader population, however also creates a 
potential for differences in severity of illnesses, which no study adequately controls 
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for. No study transparently reported how many individuals that were invited 
actually took part in their study. Some studies mentioned drop-out rates, but failed 
to explain why these individuals dropped out60. Only one study53 disclosed that they 
provided control for individuals with a tendency to give socially desirable responses, 
or individuals likely to produce false-negative reports, by examining items from a 
minimization/denial scale. Another issue limiting the representativeness of the 
populations across studies is that the average percentage of females across the 
studies ranged from 0%50 to 64% 60. 
 
1.3.5 Summary of findings of reviewed papers 
Only two studies51,52 reported effect sizes, with the largest being a Cohens d of  
1.8552, which is considered a large effect size. However, this was for a group 
comparison between patients that were abused, versus all controls (regardless of 
abuse), in overall cognitive ability. It is unclear why the authors report this effect 
size, as opposed to one that more adequately would assess those controls that 
were abused, versus the patients that were abused. Only one other study51 reported 
effect sizes, comparing a “trauma positive” and “trauma negative” group in 
different cognitive domains, but quoting small effect sizes.  
Findings differed across the studies. Some of the studies found that CT was 
associated with impaired performance in specific cognitive abilities, such as 
memory, working memory, attention, and language, premorbid IQ, and used only 
patient samples50,51,54. One study used both patients and controls, however only 
included in their CT and cognitive ability associations a subsample of 45 patients57. 
Two studies that only utilized patients found no association between measures of 
CT and cognitive ability52,53 . Two  studies58,65  included both patients and controls, 
and found no significant associations between cognitive ability and CT in any of the 
tested cognitive domains.  Two studies found effects in controls but not patients in 
full-scale IQ 55,64. Two studies56, 66 found impaired performance in cognitive ability in 
relation to higher CT in several domains such as, verbal intelligence, language, 
attention, and concentration. Other studies found effects in several cognitive 
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domains for both patients and controls52,61,63. The one study59 that utilized a high 
risk sample but not a control group, found that the CTQ physical trauma subscale 
negatively associated with tests of attention and executive function. A detailed 
summary of the main findings of each study along with relevant considerations 
pertaining to their statistical analysis that will be discussed in subsequent sections, 
are presented in Table 1.
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Table 1. Table of Key findings and values on association between Childhood trauma and Cognitive Ability, and relevant 
sample/measure/statistical considerations. Relevant methodology has been extracted from the reviewed papers and is included in the 
table below. P = patients, HC = healthy controls 
Authors Sample  Childhood Measure Utilized and analysis method 
of CTQ measure 
Key findings and values on association between 








Li et al. 
2017
60 
P=162 CTQ, 28 item
1 
 
Total score of CT. 
 
Dichotomized physical abuse, sexual abuse, 
emotional abuse, physical abuse and emotional 







Physical and sexual abuse significantly negatively 
correlated with language score (r = −0.190, −0.216, 
respectively, p < 0.05).  
 
Physical neglect and total score of CTQ negatively 
correlated with the attention score (r = −0.17, −0.206, p < 
0.05, respectively) as well as the total RBANS score (r = 
−0.199, −0.223, respectively P < 0.05).  
 
PN negatively correlated with delayed memory (r = 
−0.167, p b 0.05).  
 
Regression analysis 
PN  and attention, and the cognitive total score, Multiple 
regression: odds ration = 91.047, confidence interval, 
75.037 ~ 107.063 , p  < 0.001 
No control for any factors 
on the correlation analysis.  
 
No control for multiple 
comparisons 
 
For the  multiple regression: 









Kelly et al. 
2016
53 
P = 100 CTQ, 28 Item
1
. Only utilized physical abuse using 
cut-off criteria for low to moderate/high 
 
 
RBANS total score and found no significant differences in 
either men or women, or a physical abuse by sex 
interaction in RBANS total score.  
Age, race, and level of 
education 
 









Authors Sample  Childhood Measure Utilized and analysis method 
of CTQ measure 
Key findings and values on association between 









Green et al. 
2014
62 
P = 617 
Only conducted in the 





total childhood adversity  scores entered into  
analyses as continuous variable as well as separate 
categories for physical abuse, emotional neglect, 
emotional abuse, as continuous variables 
No association total childhood cognitive measure. No control for confounding 






Van Os Et 
al. 2017
55 
Patients  with non-
affective psychosis  = 
1119 
 
Siblings of patients N = 
1059 




general abuse factor from sums of all categories, 
as well as  emotional and physical neglect, and as 
total CT score 
 
CT analysed as a continuous variable 
 and a dichotomous variable 
 
 
CT in controls associated with significant reduction in IQ (-
4.85, 95% confidence interval 95%CI: 7.98 to -1.73 p = 
.002), lesser reduction in siblings, (-2.58, 95% CI = -4.69 to 
-0.46, p = 0.017, no significant reduction in patients (0.84, 
95% CI = -2.78 to 1.10, p = .398. 
Age, sex, ethnic group 
educational level, CAPE 
total score, cannabis use.   
 
 











79 individuals with 
early psychosis (P) 
 




.  Conducted analyses separately for 
emotional, sexual, physical abuse and emotional 
and physical neglect, as well as using  total CTQ 










No significant differences found in any of the tested 
cognitive domains ( p ns) 
  
Adjusted for age, gender 
and education status 
 
No control for multiple 
comparisons in the 
correlations analysis 
 
Multiple linear regression 
analyses were adjusted for 
false discovery rate  
Authors Sample  Childhood Measure Utilized and analysis method 
of CTQ measure 
Key findings and values on association between 












167 bipolar patients 
CTQ 28 item
1
  data dichotomized into two groups 
(low or high trauma) subscale  for physical, sexual, 
emotional abuse and emotional and physical 
neglect. 
 
When general cognition as measured by the WASI was 
added to the model, CAE and specific cognitive domains 
no longer reached the level of statistical significance 
 
General IQ score 
 
Coefficient 0.09, se = 0.01, t = 11.02,  p 0.001* 
Analysis controlled for 
performance and verbal 
tasks from WASI, age and 
gender 
 
Controlled for multiple 






navari et al. 
2012
57 
83 FEP, 63 HC 
 
 




Defined as exposure to one or more of the 
following: severe physical abuse, 
severe sexual abuse, parental loss or separation  
and total score 
 
dichotomized  into  severe and non-severe 
categories 
Childhood trauma was also significantly negatively 
correlated with performance on the following domains: 
executive function and working memory (p=0.02; r=−0.3); 
attention and concentration (p=0.01; r=−0.3); language 
(p=0.04; r=−0.3); verbal intelligence (p=0.02; r=−0.3). 





Only 45 sub sample 
conducted the trauma 
measure though 















Defined as exposure to one or more of the 
following: severe physical abuse, 
severe sexual abuse, parental loss or separation 
 








Trauma associated with a significant decrease in verbal 
intelligence domain(P=0.035), the language domain 
(P=0.044), and the attention, concentration and mental 
speed domain (P=0.047) 
 
No differences in pre-morbid IQ in the patients with and 
without trauma 
 
No effects of trauma were found in the controls. 
 
Ethnicity and education 
Authors Sample  Childhood Measure Utilized and analysis method 
of CTQ measure 
Key findings and values on association between 







Sideli et al. 
2014
56 
P = 134 
HC =124 
Childhood physical and sexual abuse 




Analyses limited to physical abuse resulting in 
injuries and to penetrative sexual abuse. 
Dichotomized as present or not 
 
No patient differences in general intellectual ability or 
cognitive function.  
 
abused controls performed worse than non-abused 
controls in the executive function t(1,122) 2.60, p = 0.019 
and working memory domain, t (1,122) = 3.06, p = 0.003) 
Gender, age, ethnicity, and 
education level 
 
No control for medication 
 
Bonferroni correction for 




Green et al. 
2015
63 
P = 617 
HC = 659 
 
 
The Childhood Adversity Questionnaire
2 
 
The CAQ comprises 20 items (scored as yes or no) 
that assess experiences of physical abuse, 
emotional abuse, sexual abuse, emotional abuse, 
emotional neglect, and family dysfunction.
 
Only items pertaining to deliberate maltreatment 
Patients 
Rbans total  
B = 10.35, confidence interval (2.74-74,96, t = 2.68, p = 
0.01 
Rbans attention B = 19,35, confidence interval = 2l65 – 
21.27) 
RBANs language = beta (8.81, confidence interval = 1.98, 
No control for confounding 
factors 
 
No control for multiple 
comparisons 
 
Regressions conducted for 
patient and control groups 
separately. 
Doctorate in Clinical Psychology 
Catherine Bois 
2018  
(not adverse living circumstances) were used  15.65, t = 2.53, p 0 .01) 
Controls 
RBANS attention 
Beta = 11.56(2.61-20.52), t = 2.55, p = .01 
WTAR beta 6.55 (0.45-12.65, t = 2.12 (0.04) 




Authors Sample  Childhood Measure Utilized and analysis method 
of CTQ measure 
Key findings and values on association between 










P = 85, CTQ, 28 item version
1 
Participants separated into (child trauma positive 
and child trauma negative)  
WMS-III logical memory Immediate recall , F = 2.83, p = 
0.044, n2 = .099 
Delayed recall = f = 2.85, P = 0.043, PARITAL ETA SQUARED 
= 0.1 
WMS-III WORD LISTS  
Recognition F = 3.29, P = 0.025, partial eta squared= 0.114 
WMS-III letter-number sequencing 
Total score F = 6, p = 0.001, partial eta squared = 0.189 
Covarying for depression 
levels and estimates of 
premorbid IQ 
 
No control for multiple 
comparisons 











disorder (n = 56) 
HC = 52 
CTQ, 25 Item
3 
CTQ scores grouped into an abuse score (sexual 
abuse + physical abuse  + emotional abuse score) 
and a neglect score (physical neglect  + emotional 
neglect score) 
No type childhood abuse associated with cognitive 
impairments on any of the MCCB domains, p ns 
 
 
Educational level and 
depression patient group.  
 









P = 408 
HC = 267 
modified version of the childhood adversity 
questionnaire
2
  five or more childhood adversities, 
compared to zero, 
Factor analysis of the 19 CAQ items identified 5 
factors with Eigen values >1 (see Table 2); Abusive 
Parenting (Factor 1); Loss, Poverty and Sexual 
Abuse (Factor 2); Neglectful Parenting (Factor 3); 
Dysfunctional Parenting (Factor 4) and Sibling Loss 
(Factor 5). 
 
Effects in controls only, not patients 
Exerience of 5 or more childhood adversities (compared to 
9 associated with significant decrease in both WTAR verbal 
Mmean – 106,4, SD = 10.2 vs 114, SD = 9.4, Tukey = -7.00 
(SE = 1.89), p = 0.001) and WASI (mean = 112.0, SD = 12.7 









age, gender and education 
 




Authors Sample  Childhood Measure Utilized and analysis method 
of CTQ measure 
Key findings and values on association between 













168 individuals with 
schizophrenia spectrum 
disorder, 
n = 50 non-psychotic 
individuals with similar 
age and education 
BUT ONLY USED A SUB 
SAMPLE OF 62 FOR THE 
ACTUAL THING?? 
MACE scale developed to capture 10 forms of ACE 
between infancy and age 18. For each of the 75 
items (assigned to 10 subscales) experience was 
coded as yes-no. 
For each subscale, positively endorsed items were 
linearly interpolated to obtain severity scores that 
range from 0 to 10.  
Overall severity of ACE was calculated using the . 
Sum of all 10 subscale-severities (ranging from 0 to 
100) 
BminMSE= beta estimates based on the optimal lambda to 




 Abuse sum age 3  BminMSE  −0.90  SD 2.53 (0.16) p = 
0.0016 patient abuse versus no abuse  d = 0.65 patient no 
abuse versus  d = 1.20 patients abuse versus controls  d = 
1.85 
Attention 
Abuse sum age 3  BminMSE=  −0.77 ,SD 2.25 (0.26) p = 
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50 non psychotic HC 
from general 
population 
 0.00006 patient abuse versus no abuse d = 0.24 patient no 
abuse versus controls  d = 0.73 patients abuse versus 
controls d = 0.95 
Working memory 
Abuse sum age 3  BminMSE −0.04 SD =  1.31 (0.09) p = 
0.0102 patient abuse versus no d = 0.57  patient no abuse 
versus controls  d = 0.63 patients abuse versus controls  d 
= 1.19 
Verbal learning 
BminMSE  = −0.50 SD = 1.61 (0.13) p = 0.0036 patient 
abuse versus no  d = 0.67 patient no abuse versus controls   
d = 0.43c patients abuse versus controls  d = 1.10 
Visual Learning 
Abuse sum age 3 BminMSE  −0.65  SD 1.77 (0.17) p = 0.006 
patient abuse versus no  d = 0.51 patient no abuse versus 
patients abuse versus controls     d = 0.58 d = 1.10 
 
 
Authors Sample  Childhood Measure Utilized and analysis method 
of CTQ measure 
Key findings and values on association between 








Ucok et al. 
2016
59 
53 UHR CTQ, 25 item 
3 
 This study dichotomized the sample by using cut-
off scores for the presence of emotional, physical 
and sexual trauma and physical and emotional 
neglect.   
 
CTQ-physical trauma subscale negatively associated with 
WCST completed categories (rho = −0.465, p = 0.002), 
Stroop-word reading time (rho = 0.42, p = 0.003), Stroop-
color reading time (rho = 0.44, p = 0.002),  
CTQ-physical neglect subscale scores were correlated with 
the Digit Span Forward test scores (rho = −0.41, p = 0.004) 
P ns:  emotional/sexual trauma in terms of cognitive 
performance, childhood emotional neglect.  
Ultra high risk sample. 
No control for any 
confounding factors 
 




P = 89 , healthy non- CTQ, 25 item
3 
CT negatively associated with BD performance (B 
- 120, x = -2.29, CI 95% 223.47 to -17.47, p = 0.02) 
Controlled for substance 
use  and cumulative 








psychotic siblings = 95  Calculating the mean of the 25 items resulted in a 
general measure of CT. 
 
CT  not associated with AVLT performance ( p ns) 
 
No significant CT by group interaction in delayed AVLT/BD 













P = 40 Structured social history interview of childhood 
abuse/neglect 
Patients with history of PA, SA, and neglect. 
Groups divided based on types of abuse they 
experienced (i.e., zero, one type, two or more). 
Tests for a linear trend across groups indicated significant 
effects for both the premorbid (F(1,39)=6.73, p b.05) and 
clinical cognitive (F(1,39)=22.28, p b.001) factor scores 
(both tests using unweighted estimates clinical factor that 
represented greater symptomatology and more impaired 
cognitive functioning 
MANOVA, no control for 








43 patients  with 
schizophrenia or 
schizoaffective disorder 
Sexual abuse based on unnamed  questionnaire 
derived from  Levitan et al. (1998)
5 
MANCOVA comparing neurocognitive test scores, using 
age and vocabulary as covariates, indicated significant 
group differences ( f(9, 31) = 5.53, p < .001). 
Patients with SA abuse had impaired processing speed, 
working memory, and executive function compared to 
patients ( f(9, 31) = 5.53, p < .001). reporting no abuse.  
Age and premorbid IQ 
 
 
References for Table 2 
1. Bernstein DP, Stein JA, Newcomb MD, et al. Development and validation of a brief screening version of the childhood trauma questionnaire. Child Abuse Negl. 2003;27:169–90 
2. Rosenberg SD, Lu W, Mueser KT, Jankowski MK, Cournos F. Correlates of adverse childhood events among adults with schizophrenia spectrum disorders. Psychiatric Services 
2007;58(2):245e53 
3. Bernstein DP, Ahluvalia T, Pogge D, Handelsman L. Validity of the Childhood Trauma Questionnaire in an adolescent psychiatric population. J Am Acad Child Adolesc Psychiatry. 
1997;36:340–348. 
4. A. Bifulco, O. Bernazzani, P.M. Moran, C. Jacobs The childhood experience of care and abuse questionnaire (CECA.Q): validation in a community series Br. J. Clin. 
Psychol., 44 (2005), pp. 563-581 
5. Levitan RD, Parikh SV, Lesage AD, Hegadoren KM, Adams M, Kennedy S, Goering PN: Major depression in individuals with a history of childhood physical or sexual abuse: 
Relationship to neurovegitative features, mania and gender. Am J Psychiatry 1998; 155:1746–1752 
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1.3.5.1 Factors influencing the quality of the conceptualisation of CT/CA across the 
reviewed studies 
Different measures, as well as conceptualisations of CT/ACE occurred across the 
reviewed studies. Several studies failed to mention the reliability and validity of the 
measures they used 16,65-68, 49,50,51-53 . None of the studies mentioned how, or if, they 
attempted to contain the potentially distressing nature of the content listed in most 
of the CT measurements. Some studies covered reliability and validity well by 
covering whether the psychometric properties such as reliability and validity had 
also been considered for patients with psychosis58, 59,54. 
 
Only one study52 looked at timing, as well as quantifying severity of the trauma. Two 
papers62,63 utilized the Childhood adversity questionnaire68 which assesses sexual 
trauma from the parent only, which means sexual trauma from other perpetrators  
may have been under reported. Many of the studies included for the review were 
conducted in different countries, and although some studies mention whether the 
CT measure is normed to their country/population56,60 some do not57, 66,67 and thus 
the potential for cross-cultural differences, such as differences in social desirability 
items, and full disclosure, remains a potentially confounding factor across all of the 
studies. It is crucial to note that all measures of the reviewed studies are 
retrospective in nature, and retrospective recall may critically depend on a person’s 
cognitive ability, substance misuse, as well as diminish in accuracy when clouded by 
psychotic experiences and their severity, as well as affective symptoms of patients. 
 
As is clear from Table 1, there is clear cross study variability in how the same 
measure of CT is subsequently used for the statistical analysis, as studies varied in 
what item score was considered having mild/moderate/severe exposure to CT, or 
whether they were included in the analysis as a continuous variable or based on 
median split. Studies also varied in which types of abuse and/or neglect were 
analysed, or whether a total sum of abuse/neglect was included. For example, two 
studies62,63, that used the same sample of controls and patients and questionnaire, 
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used different methods of defining levels of trauma, resulting in the control group 
being excluded in one of their papers due to low levels of trauma, whilst the other 
study includes them by approaching trauma differently. This exemplifies how the 
inconsistency of the conceptualisation of CT across the reviewed studies creates a 
lack of combinability that has profound implications for the quality and accuracy of 
the reviewed papers. 
 
1.3.5.2 Factors influencing the quality of the conceptualisation of cognitive ability 
across the reviewed studies 
Most of the cognitive variables across the studies were well-known, standardized 
measures (For a breakdown of these and the cognitive domains tested, please see 
Table 2). However often studies would not mention reliability or validity for the 






















Table 2. Table of all the tests utilized across the studies, and what cognitive domain 
they represent. Numbers of papers are as follows: Li et al60 = 1, Van Os et al55 =2, 
Garcia et al19 =3, Ucok et al59 = 4, Sideli et al56 = 5, Aas & Steen et al67 = 6, Lysaker et 
al50 =7, McCabe et al64 = 8, Schalinski et al52, = 9 , Kelly et al53 = 10, Kilian et al58 = 11, 
Aas, Dazzan et al66 = 12, Shannon et al51= 13, Schenkel et al54 =14, Green et al63 =15, 
Green et al62 =16, Hernaus et al61=17, Aas, Navari et al57=18 







RBANS subdomain word list 1, short story 11 1,  15, 16, 10 
The California Verbal Learning Test 2 6,  7 
Rey Auditory Verbal Learning Test3 18 17, 4 
Visual reproduction subtest of the Wechsler Memory Scale4 18 
Immediate scores of the Visual reproduction task of the 
Wechsler Memory Scale4 
5 










RBANS subdomain word list 2, word list recognition, story 2 , 
figure recall1 
1, 10,  15, 16 
The California Verbal Learning Test2 6, 7 
Rey Auditory Verbal Learning Test3 12, 18, 4 
Visual reproduction subtest of the Wechsler Memory Scale—
Revised (Wechsler, 1987)4 
12, 18 
Delayed scores of the Visual reproduction task of the Wechsler 
memory scale4 
5 
Delayed scores of the Logical memory task of the Wechsler 
Memory Scale 
5, 13 
Auditory verbal learning task from the Wechsler adult 





RBANS subdomain  Figure Copy, line orientation1 1 10, 15, 16 
Block Design from WAIS-R, block design from Wechsler adult 
intelligence scale 4th edition5 
2 , 18, 17 
Brief Visuospatial Memory Test-Revised6 3, 11,  9 
A of Raven's Colored Progressive Matrices7 12, 18 







Trail Making Test Part B9 12, 18,4, 5 
Controlled oral word association test10 15, 16 , 14 
Wisconsin Card Sorting test11 7, 4 
Brixton spatial anticipation test12 14 
hayling sentence completion test from the hayling Brixton 
tests12 
14 
Neuropsychological Assessment Battery mazes13  3, 11,  9 
Raven's Colored Progressive Matrices sets A & B7 12,18 





RBANS subdomain Picture naming, semantic fluency1 1, 10, 15 , 16 
Information from Wechsler adult intelligence scale 4th edition5 2 
Semantic fluency5  12,18,5 
Category fluency5 12, 18,  5 
Vocabulary and comprehension subtests from Wechsler adult 
intelligence scale-revised15  
12  





RBANS subdomain digit span, coding1 1,  10, 15, 16 
Arithmetic from WAIS5 2 
digit symbol subtest WAIS-R15 18, 5 , 2 
Continuous Performance Test-Identical Pairs13 3,  11 ,9, 4 






Attention/working memory  
Letter–Number Span Test Wechsler abbreviated intelligence 
scale17 
6, 18, 12 
Digit span5 6, 18 
Digit span of the WAIS5 5 
Letter-number sequencing from wechsler memory scale4 13 
forward and backward digit span4  6 , 4 
Spatial span of the Wechsler memory scale4 5 
Stroop test14 4 





Brief Assessment of Cognition in Schizophrenia-Symbol Coding13   3, 11, 9 
Hopkins Verbal Learning Test-Revised  WMS Spatial Span4   3,  11, 9 
University of Maryland Letter–Number Span13   3, 11, 9 





General Cognitive Functioning 
WAIS5 2,5 
WASI 17 6 , 8 





Some studies53,60,62,63 utilized the Repeatable Test for the Assessment of 
Neuropsychological Status (RBANS)69. This test was originally developed as a 
screening measure primarily for elderly individuals and may therefore be more 
relevant for the types of impairment observed in patients with dementing illnesses, 
References for Table 2 
1. Randolph C, Tierney MC, Mohr, E, et al. The repeatable battery for the assessment of neuropsychological 
status (RBANS): Preliminary clinical validity. J Clin Exp Neuropsychol, 1998; 20:3, 310-319  
2. Delis, D. C., Kramer, J., Kaplan, E., Ober, B. A., Fridlund, A.The California Verbal Learning Test.1987, New York: 
Psychological Corporation. 
3. Lezak MD). Neuropsychological assessment (2nd ed. ). 1983, New York: Oxford University Press. 
4. Wechsler, D. (1987). Wechsler Memory Scale New York: Psychological Corporation  
5. Wechsler, D. Wechsler Adult Intelligence Scale—Fourth Edition. 2008, San Antonio, TX: Pearson Assessment. 
6. Benedict, R. Brief Visuospatial Memory Test–Revised. 1997;Odessa, FL: Psychological Assessment Resources. 
7. Raven, J. Standard progressive matrices: Sets A, B, C, D & E.  1976, Oxford: Oxford Psychologists Press 
8. Kovacs, I., Kozma, P., Feher, A., Benedek, G. Late maturation of visual spatial integration in humans. Proc. Natl. 
Acad. Sci. 1999;96, 12204 – 12209. 
9. Lamberty, G. J., Putnam, S. H., Chatel, D. M., Bieliauskas, L. A., & Adams, K. M.  Derived Trail Making Test 
indices: A preliminary report. Neuropsychiatry; Neuropsychology, and Behavioral Neurology, 1994;7, 230–
234. 
10. Patterson J. Controlled Oral Word Association Test. In: Kreutzer J.S., DeLuca J., Caplan B. (eds) 
Encyclopedia of Clinical Neuropsychology. 1994. Springer, New York, NY 
11. Heaton, RK 1981. Wisconsin Card Sorting Test Manual. Odessa, FL: Psychological assessment resources, 
Inc.  
12. Burgess PW, Shallice T 1997.The Hayling and Brixton Tests. UK: Thames Valley Test Company Limited. 
13. Kern, RS, Nuechterlein KH, Green MF, et al. The MATRICS consensus cognitive battery, Part 2: Co-norming and 
standardization; 2008; 165:2, 214-220.  
14. Stroop KR. Studies of interference in serial verbal reactions. J Exper Psychol; 1935, 18, 643-661. 
15. Wechsler, D., 1981. Wechsler Adult Intelligence Scale — Revised (Manual). The Psychological Corporation Inc., 
USA. 
16. Shipley, WC. Shipley Institute of Living Scale: For measuring intellectual Impairment. Western Psychological 
services 
17. Psychological Corp 1999. Wechsler abbreviated Scale of Intelligence manual. San Antonio, TX, Author. 
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as opposed to psychosis, and it may also be implicated in ceiling effects for the 
control groups, which was not considered across the studies.  
 
Another important issue when including individuals with psychosis is considering 
the increased risk of fatigue, severity of psychotic symptoms, lack of attention all 
contributing to floor effects70 which may affect the test validity, sensitivity and/or 
specificity of the cognitive testing. No study adequately explained how they 
controlled for issues of fatigue, or ensuring that the individual sustained attention 
during the assessment. Studies also varied in their inclusion of premorbid IQ, and 
whether this was included in subsequent statistical analysis. This is a crucial point to 
consider if other aspects of the psychotic disorder, such as symptom severity were 
not accounted for.  
 
Studies also varied in their age ranges.  Across the reviewed studies, average age for 
patients ranged from 23.858 to 4550, with one study60 reporting that the range of 
individuals approached was between 16 to 75. Crucially, length of illness, chronicity 
of symptoms and medication use, have all been highly associated with cognitive 
impairments in psychosis67-73. Thus any reported associations between the 
measures of CT/ACE and cognitive ability may be critically confounded, unless these 
factors are appropriately controlled for. Only 5 studies used samples of individuals 
in the early stages of their psychotic disorder56-58 65,66,, two of which use subsamples 
drawn from the same participant pool57,66. Only one of the reviewed studies59 uses 
a clinical high risk sample, which to a certain extent provides more information 
regarding the target population without the confounds of length of 
illness/antipsychotic medication, however this study did not include a control 
group, which limits the conclusions we can make regarding the specificity of their 
results to psychosis.  
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1.3.5.3.1 Control for confounding variables affecting quality of cognitive ability 
and CT/ACE utilized across studies  
 As cognitive ability has been associated with education and full scale IQ74 estimates 
of years in education and a measure of premorbid IQ would be crucial. However, as 
is clear from Table 1, studies varied in the extent to which these were included. As 
antipsychotic medication has been highly correlated with cognitive function in 
studies of patients with psychosis75 this would have been an imperative 
confounding factor to include. Crucially, only a small minority of reviewed studies 
controlled for antipsychotic medication exposure. For example, one study60 found 
that patients undergoing treatment with atypical antipsychotics had significantly 
higher delayed memory and RBANS total scores compared to patients treated with 
first-generation antipsychotics, yet failed to include this variable in their analysis.  
 
1.3.5.3.1 Adequate inclusion of controlling for multiple comparisons across 
reviewed studies 
Some studies were found to control for multiple comparisons well throughout, by 
using by stringent Bonferroni corrections on the p values obtained for each 
test60,64,65 or at least indicating which tests remained significant after bonferroni 
testing. However, other studies did not report any control for multiple comparisons, 
or adjust their regression analysis for false discovery rate, yet conducted several 
correlations between different cognitive tests and different types of abuse, 
providing high risk of Type 1 errors. Two studies50,54  used a multivariate analysis of 
variance (MANOVA) which is a method by which the risk of Type 1 errors is 
minimised. However, often significant effects are followed up by subsequent 
ANOVAs. However, the original MANOVA protects only the dependent variable for 
which group differences genuinely exist76 and thus some authors suggest that these 
subsequent ANOVAS should also be controlled for multiple comparisons77, which 
the authors do not do.  Other studies did not need to control for multiple 
comparisons to the same extent 55, as they looked at full scale IQ. The studies that 
utilize sibling/case designs control for the family effect well, by using family 
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structure55,61  in their random intercept multilevel regression models, protecting 





1.4.1 Summary of reviewed papers 
 
To summarise, this review identified 18 studies that have looked at the association 
between CT/ACE and cognitive variables in individuals with psychosis. In brief, study 
findings are diverse, and no clear conclusion can be drawn on  whether patients or 
controls show more impaired cognitive ability in association with adversity. 
However, the systematic review of the literature highlights that adverse events may 
have an effect on both localised and globalcognitive domains, suggesting that 
further more rigorous and well-controlled studies are required.  
 
However, a lack of transparent reporting of effect sizes across reviewed studies, and 
differences across group comparisons limit the generalisability of the existing 
evidence. Furthermore, the different conceptualisations of CT/adversity and 
cognitive ability, combined with a general lack of inclusion of appropriate 
confounding factors and adequate control of multiple comparisons, critically limit 
any robust interpretation of the reviewed evidence base. Although ten of the 
studies reported including control groups, there was clear cross-study variability in 
their inclusion in subsequent analysis, which further limits the conclusions that can 
be drawn from the reviewed evidence-base. 
  
In order for any reported association between ACE and cognitive ability to be 
considered robust and generalizable across studies, the quality of the included 
cognitive variables is imperative. However, the chronicity of samples across the 
reviewed papers, along with inadequate control for medication, length of illness, 
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and symptom severity, critically limit the quality of the cognitive variables tested. 
Furthermore, as many studies include several tests spanning several cognitive 
domains without use of appropriate control for multiple comparisons, the risk of 
Type 1 error remains rife across the present studies. 
 
Several issues with the conceptualisation of CT/ACE limit the quality of the reviewed 
papers. Evidence has emerged that both the timing and cumulative nature of 
adversity may be important, especially if contributing to subsequent brain 
development78 and thus this limits some of the conclusions that can be made 
regarding the way in which the reviewed studies conceptualise trauma. In brief, 
some of the studies separated their measures for sexual, physical and emotional 
abuse/neglect and differed in their subsequent inclusion in analysis, and/or 
summing the total score into one generic “trauma” score. Furthermore, no study 
considered how the socio-economic status or mental health and/or intelligence of 
household may have affected upon the results.  
 
1.5.2 Implications for research 
Our review highlights that across the reviewed studies, the measurement of 
childhood adversities has been heterogeneously conceptualised, and that there is a 
lack of detail on the severity for the individual as well as timing of the trauma. 
Adversities rarely occur in isolation, and therefore studies considering the 
cumulative effect of trauma on cognitive ability are required. Furthermore, most 
studies investigated CT in a more narrow definition, and future studies looking at 
the cumulative effect of ACEs are required, such as household dysfunction, mental 
health of parents and poverty are also required, as evidence suggests these may be 
equally implicated in psychosis78.  
 
Some of the heterogeneity in the findings may be attributed also to the way in 
which the patient groups were defined, and control of patient characteristic 
confounding variables. Future studies may wish to examine severity of psychotic 
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symptomology, or medication, in relation to the link between early adversity and 
cognitive ability, rather than solely considering diagnosis, as this may provide more 
in depth information on the putative link. Furthermore, future studies of early 
psychosis samples are also required in order to minimize the confounding effect of 
antipsychotic medication, length of illness and other confounding characteristics 
mentioned above.  
 
1.5.3 Limitations of this review 
One limitation of the present study is that the literature regarding genetic 
predispositions to psychosis was not investigated or reviewed, in the context of 
potential interaction with ACE and cognitive ability. There is some evidence 
indicating an abnormal HPA axis in patients with psychotic disorders irrespective of 
early trauma and evidence of systemic cortisol metabolism79 with links to genetic 
markers in psychosis80,81. Future studies should aim to also review the evidence 
relating to this how it may interact with ACE We did not assess other important 
variables, such as psychotic symptom severity, interpersonal factors, attachment 
and PTSD symptomology/comorbidity, which may moderate or mediate the 
relationship between CT and cognitive ability in psychosis.  
 
1.5.4 Conclusions  
In conclusion, the differences in sampling methods, statistical analysis, and the 
quality of the trauma and cognitive variables included, limit the conclusions on the 
extent to which ACEsimpacts on cognitive ability, and whether it occurs only in 
individuals with psychosis, or is a more general risk mechanism for impaired 
cognitive ability in the typical population too. Crucially, many reviewed studies did 
not control for length of illness, antipsychotic/antidepressant medication, and 
future studies utilizing early psychosis/high risk samples are essential. This review 
underscores the importance of more extensive research utilizing more detailed 
assessments of exposure to adversities throughout childhood and adolescence, and 
a more theoretically informed selection of cognitive variables. The evidence 
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remains in the early stages, and future research in this area is necessary before any 





























Doctorate in Clinical Psychology 
Catherine Bois 
2018  
References Systematic Review 
1. Dvir Y, Denietolis B, Frazier JA. Childhood trauma and psychosis. 
Child Adolesc Psychiatr Clin N Am,2013;22:629-641. 
 
2. Kessler RC, McLaughlin KA, Green JG,  et al. Childhood adversities and adult 
psychopathology in the WHO World Mental Health Surveys. Br J Psychiatry, 
2010; 197:5, 378-385. 
 
3. Matheson SL< Shepart AM, Pinchbeck RM, et al. Childhood adversity in 
schizophrenia: a systematic meta-analysis. Psychol Med,2013; 43:2, 225-
238 
 
4. Read, J., Van Os, J., & Ross CA. Childhood trauma, psychosis and 
schizophrenia: a literature review with theoretical and clinical implications. 
Acta Psychiatr Scand, 2005; 112:5, 330-350.  
 
5. Bendall, S, Jimenez-Alvarex M, Hulbert CA, McGorry PD, & Jackson HJ. 
Childhood trauma increases the risk of post-traumatic stress disorder in 
response to first-episode psychosis, 2012; 46:1,35-39 
 
6. Morgan, C & Fisher H. Factors in schizophrenia: Childhood trauma-A critical 
review. Schizophr Bull, 2007; 33:1, 3-10 
 
7. Baudin G, Szoke A, Richard JR, Pelissolo A, Leboyer M, & Schurhoff F. 
Childhood trauma and psychosis: beyond the association. Child Abuse Negl; 
2017;72:227-235  
 
8. Reeder FD, Husain N, Rhouma A, et al. The relationship between childhood 
trauma and adult psychosis in a UKA early intervention service: results of a 
retrospective case note study. Neuropsychiatr Dis Treat, 2017; 13: 269-273 




9. Varese F, Smeets F, Drukker M, et al. Childhood adversities increase the risk 
of psychosis: a meta-analysis of patient-control, prospective and cross-
sectional cohort studies. Schizophr Bull, 2012; 38:4, 661-671 
 
10. Torniainen,  M, Jaana S, PArtonen T, et al. Cognitive impairments in 
schizophrenia and schizoaffective disorder: relationship with clinical 
characteristics. J Nerv Ment Dis, 2012, 200:4, 316-322 
 
11. Seidman LJ, Pousada-Casal A, Scala S, et al. Auditory vigilance and working 
memory in youth at familial risk for schizophrenia or affective psychosis in 
the Harvard adolescent family high risk study. J Int Neuropsychol Soc, 
2016,22:10, 1026-1037 
 
12. Knowles EEM, Weiser M, David AS, Glahn DC, Davidson M, Reichenberg A. 
The puzzle of processing speed, memory, and executive function 
impairments in schizophrenia: fitting the pieces together, 2015; 78:11, 786-
793 
 
13. Guimond S, Chakravarty MM, Bergeron-Gagnon L, Patel R, Lepage M. Verbal 
memory impairments in schizophrenia associated with cortical thinning, 
Neuroimage Clin, 2016; 11, 20-29 
 
14. Heinricks R, Zakzanis W, Konstantine K. Neurocognitive deficit in 





Doctorate in Clinical Psychology 
Catherine Bois 
2018  
15.  Flashman LA, Green MF. Review of cognition and brain structure in 
schizophrenia: profiles, longitudinal course and effects of treatment. 
Psychiatr Clin North Am, 2004; 27:1, 1-18 
 
16. Schaefer J., Giangrande E., Weinberger DR., Dickinson D. The global 
cognitive impairment in schizophrenia: consistent over decades and around 
the world. Schizophr Res, 2013; 150:1, 42-50. 
 
17. Nuechterlein KH, Ventura J, Subotnik, & Bartzokis, G. The early longitudinal 
course of cognitive deficits in schizophrenia, J Clin Psychiatry, 2015, 75:0-1, 
25-29 
 
18. Fett AKJ, Viechtbauer W, Dominguez MdG, Penn DL, van os J, Krabbendam 
L.The relationship between neurocgonition and social cognition with 
functional outcomes in schizophrenia: a meta-analysis. Neurosci Biobehav 
Rev, 2011, 35(3), 573-588 
 
19. Bozikas VP., & Andreou C. (2011) Longitudinal studies of cognition in first 
episode psychosis: a systematic review of the literature. Aust N Z J 
Psychiatry, 45(2), 93-108. 
 
20.  Bora, E., & Pantelis C. (2015).Meta-analysis of cognitive impairment in first-
episode bipolar disorder: comparison with first-episode schizophrenia and 
healthy controls. Schizophrenia Bulletin, 41(5), 1095-1104.  
 
21. Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional 
outcome in schizophrenia: are we measuring the “right stuff”. Schizophr 
Bull, 2000; 26(1), 119-136 
 
Doctorate in Clinical Psychology 
Catherine Bois 
2018  
22. Liddle PF. Cognitive impairment in schizophrenia: its impact on social 
functioning. Acta Psychiatr Scand, 2000; 101(400), 11-16 
 
 
23. Milev, P, Ho BC, Arndt S, Andreasen NC, Predictive values of neurocognition 
and negative symptoms on functional outcome in schizophrenia: a 
longitudinal first-episode study with 7-year follow-up, 2005; 162:3, 495-506  
 
24. Sheffield JM, Reprovs G, Harms et al. Fronto-parietal and cingulo-opercular 
network integrity and cognition in health and schizophrenia. Neuropsychol, 
2015; 73, 82-93 
 
25.  Cannon TD. How schizophrenia develops: cognitive and brain mechanisms 
underlying onset of psychosis. Trends Cogn Sci, 2015 19:12, 744-756 
 
26. Young DA, Inslicht SS, Metzler TJ, Neylan TC, Ross JA. The effects of early 
trauma and the FKBP5 gene on PTSD and the HPA axis in a clinical sample of 
gulf war veterans, 2018, Psychiatry Res, In Press Corrected Proof 
 
27.  Misiak B, Krefft M, Bielawski T, Moustafa AA, Sasiadek MM, Frydecka D. 
Towards a unified theory of childhood trauma and psychosis: a 
comprehensive review of epidemiological, clinical, neurospycohlogical and 
biological findings. Neurosci Biobehav Rev, 201775, 393-406 
 
28.  Babenko O, Kovalchuk I, Metz GAS. Stress-induced perinatal and 
transgenerational epigenetic programming of brain development and 
mental health. Neurosci Biobehav Rev, 2015, 48, 70-91 
 
29. Gerrard B, Singh V, Babenko O, et al. Chronic mild stress exacerbates 
severity of experimental autoimmune encephalomyelitis in association with 
altered non-coding RNA and metabolic biomarkers, Neurosci, 359, 299-307 




30. Bremner JD, & Vermetten E. Stress and development: behavioural and 
biological consequences, Dev Psychopathol, 2001; 13:3, 473-489  
 
31. Teicher MH, Andersen SL, Plcari A, et al. The neurobiological consequences 
of early stress and childhood maltreatment. Neurosci Biobehav Rev,2003, 
27:1-2, 33-44 
 
32. Bois C, Ronan L, Levita L, et al. Cortical surface area differentiates familial 
high risk individuals who go on to develop schizophrenia. Biol Psychiatry, 
2015; 78:6, 413-420 
 
33. Callicott JH, Mattay VS, Verchinski BA, Marenco S, Egan MF, Weinberger DR. 
Complexity of rpefrontal cortical dysfunction in schizophrenia: more than 
up or down. J Am Psychiatr, 2003; 160:12, 2209-2215 
 
34. Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings 
in schizophrenia, Schizophr Res, 2011; 49:1-2, 1-52 
 
35. Read J, Agar K, Argyle N, Aderhold V. Sexual and physical abuse during 
childhood and adulthood as predictors of hallucinations, delusions and 
thought disorder. Psychol Psychother, 2003; 76:1, 1-22 
 
36. Freeman, D, Garety PA, Kuipers E, et al. A cognitive model of persecutory 
delusions. Br J CLin Psychol,2002; 41, 331-347. 
 
37. Courtois, CA, & Ford JD. Treating complex traumatic stress disorders: 








38.  Bailey T, Alvarez-Jimenez M, Garcia-Sanchez AM, Hulbert C., Barlow E, & 
Bendall S. Childhood trauma is associated with severity of hallucinations 
and delusions in psychotic disorders: a systematic review and meta-analysis. 
Schizophr Bull ,2018, Ahead Access. 
 
39.  Bradley AJ, & Dinan TG. A systematic review of hypothalamic-pituitary-
adrenal axis function in schizophrenia: implications for mortality. J 
Psychopharmacol ; 2010, 24:4, 4-10 
 
40.  Erjavec GN, Uzun S, Perkovic MN, et al.  Cortisol in schizophrenia: no 
associated with tobacco smoking, clinical symptoms or antipsychotic 
medication. Prog Neuropsychopharmacol Biol Psychiatry, 2017; 77:3, 228-
235 
 
41. Fornito A, & Bullmore ET. Reconciling abnormalities of brain network 
structure and function in schizophrenia. Curr Opin Neurobiol, 2015, 30:44-
50. 
 
Parnas J, Raballo A, Handest P, et al. Self experience in the early phases of 
schizophrenia: 5 year follow up of the Copenhagen Prodromal Study. World 
Psych, 2013, 10:3, 200-204.  
Shonkoff JP, & Garner AS. The lifelong effects of early childhood adversity 
and toxic stress. Pediatrics, 2012, 129:1, 232-236.  
42. National Institute for Clinical Excellence; NICE, 2009,  
 
43. Scottish Intercollegiate Guidelines Network, 2015 
 
44. Mccorry, PD., Killackey E, Yung A. Early intervention in psychosis: concepts, 
evidence and future directions. World Psychiatry, 2013; 7:3, 148-156.  




45. Terwee, C. B., Mokkink, L. B., Knol, D. L., et al. . Rating the methodological 
quality in systematic reviews of studies on measurement properties: A 
scoring system for the COSMIN checklist. Health Qual Life, 2012; 21(4), 651–
657 
 
46. Schulz, K. F., Altman, D. G., Moher, D.,et al. CONSORT 2010 statement: 
Updated guidelines for reporting parallel group randomised trials (Chinese 
version). Journal of Chinese Integrative Medicine, 8(7). 
 
47.  Scottish Intercollegiate Guidelines Network (2008). SIGN 50: A guideline 
developer’s handbook. 
 





49. Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., The PRISMA Group 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The 
PRISMA Statement. PLoS Med; 2009, 6(7). 
 
50. Lysaker P.H., Meyer, P., Evans J.D., et al. Neurocognitive and symptom 
correlates of self-reported childhood sexual abuse in schizophrenia 
spectrum disorders. Ann Clin Psychiatry,2001;  13:2, 90-92. 
 
51.  Shannon, C., Douse K., McCusker C., et al. (2011). The association between 
childhood trauma and memory functioning in schizophrenia. Schizophr Bull 
2011; 37:3, 531-537. 
 
Doctorate in Clinical Psychology 
Catherine Bois 
2018  
52.  Schalinski I., Teicher M.H., Carolus A.M., et al. (2018). Defining the impact 
of childhood adversities on cognitive deficits in psychosis: An exploratory 
analysis. Schizophr Res, 192, 351-356. 
 
53.  Kelly D.L., Rowland L.M., Patchan K.M., et al. Schizophrenia clinical 
symptom differences in women vs. men with and without a history of 
childhood physical abuse. J Child Adolesc Ment Health 2016 10(5), 1-7 
 
54. Schenkel L.S., Spaulding W.D., DiLillo D., et al. Histories of childhood 
maltreatment in schizophrenia: relationships with premorbid functioning, 
symptomatology, and cognitive deficits. Schizophr Res,2005; 76:3, 273-286 
 
55. Van Os,. J., Marsman A., van Dam, D., Simons C.J.P., GROUP INVESTIGATORS 
et al. Evidence That the Impact of Childhood Trauma on IQ Is Substantial in 
Controls, Moderate in Siblings, and Absent in Patients With Psychotic 
Disorder. Schizophr Bull, 2017; 43:2, 316-324 
 
56. Sideli L., Fisher H.L., Russo M., et al. Failure to find association between 
childhood abuse and cognition in first-episode psychosis patients. Eur 
Psychiatry, 2014; 29:1, 32-35. 
 
57. AAs, M., NAvari S., Gibbs, A., et al. (2012). Is there a link between childhood 
trauma, cognition, and amygdala and hippocampus volume in first-episode 
psychosis? Schizophr Res, 2012, 137:3, 73-79 
 
58. Kilian S., Asmal L., Chiliza, B et al. (2017). Childhood adversity and cognitive 
function in schizophrenia spectrum disorders and healthy controls: 
evidence for an association between neglect and social cognition. Psychol 
Med, Printed Ahead Access 
 
Doctorate in Clinical Psychology 
Catherine Bois 
2018  
59. Ucok, A., Kaya, H., Ugurpala, C., et al. History of childhood physical trauma 
is related to cognitive decline in individuals with ultra-high risk for 
psychosis. Schizophr Res, 2015;169(1-3), 199-203. 
 
60. Li, X-B.,Bo Q-J., Zhang G-P., et al. Effect of childhood trauma on cognitive 
functions in a sample of Chinese patients with schizophrenia. 
Compr Psychiatry 2017; 76,  147-152. 
 
61. Hernaus D., van Winkel R et al., Gronenschild E. Brain-Derived Neurotrophic 
Factor/FK506-Binding Protein 5 Genotype by Childhood Trauma Interactions 
Do Not Impact on Hippocampal Volume and Cognitive Performance, PlOS 1, 
2014; 91:3, 922-27 
 
62. Green M.J., Chia T-Y., Cairs J.M., et al. Catechol-O-methyltransferase 
(COMT) genotype moderates the effects of childhood trauma on cognition 
and symptoms in schizophrenia. J Psychiatr Res, 2014; 49, 43-50 
 
63. Green M.J., Raudino A., Cairns M.J., et al. Do common genotypes of FK506 
binding protein 5 (FKBP5) moderate the effects of childhood maltreatment 
on cognition in schizophrenia and healthy controls. J Psychiatr Res, 2015; 
70, 9-17. 
 
64. McCabe K.L., Maloney E.A., Stain H.J, et al. Relationship between childhood 
adversity and clinical and cognitive features in schizophrenia.  J Psychiatr 
Res, 2012;46:5, 600-607. 
 
65. Garcia, M., Montalvo I., Creus M., et al.  Sex differences in the effect of 
childhood trauma on the clinical expression of early psychosis. Compr 
Psychiatry 2016;68, 86-96. 
 
Doctorate in Clinical Psychology 
Catherine Bois 
2018  
66. AAs, M., Dazzan P., Fisher H.L., et al. (2011). Childhood trauma and 
cognitive function in first-episode affective and non-affective psychosis. 
Schizophr Res, 129, 12-19. 
 
67. AAs M., Steen, N.E., Agartz I., et al. (2012). Is cognitive impairment 
following early life stress in severe mental disorders based on specific or 
general cognitive functioning? Psychiatry Research, 198, 495-50 
 
68.  Rosenman S, & Rodgers B. Childhood adversity in an Australian population. 
Soc Psych and Psych Epid, 2004; 39:9, 695-702) 
 
69. Randolph C, Tierney MC, Mohr, E, et al. The repeatable battery for the 
assessment of neuropsychological status (RBANS): Preliminary clinical 
validity. J Clin Exp Neuropsychol, 1998; 20(3), 310-319  
 
70. Duff, MC, Mutlu B, Byom L, Turkstra LS. Distributed cognition as a 
framework for studying discourse in adults with acquired brain injury, 
Seimn Speech Lang, 2012; 33:1, 44-54 
 
71. Husa AP, Moilanen J, Murray GM, et al. Lifetime antipsychotic medication 
and cognitive performance in schizophrenia at age 43 years in a general 
population birth cohort. Psychiatry Res, 2017; 247, 130-138. 
 
72. Perkins DO, Hi H, Boteva K, Lieberman JA. Relationship between duration of 
untreated psychosis and outcome in first-episode schizophrenia: a critical 
review and meta-analysis. Am J Psychiatry 2005; 162:10, 1785-1804 
 
73. Hausswolff-Juhilin YV, Bjartveit M, Lindstrom E, & Jones P. Schizophrenia 
and physical health problems, Acta Psychiatrica Scand, 2009; 119:(suppl 
338), 15-21 




74. Campbell FA, Pungello EP, Miller-Johnson S, Burchinal M, & Ramey CT. The 
development of cognitive and academic abilities: growth curves from an 
early childhood educational experiment. 2001; 37:2, 231-242. 
 
75. Keefe RSE, Gldberg TE, Harvey PD, et al. The brief assessment of cognition in 
schizophrenia: reliability, validity, and comparison with a standard 
neurocognitive battery.  Schizophr Res, 2004; 68:2, 283-297 
 
76. Bray, JH,  &Maxwell SE. Multivariate analysis of variance. USA, 1985 
 
77. Borgen FH, & Seling MJ. Use of discriminant analysis following MANOVA: 
Multivariate statistics for multivariate purposes.  J Appl Psychol, 1978;63:6, 
689-697 
 
78. Morgan C., & Gayer-Anderson C. Childhood adversities and psychosis: 
evidence, challenges, implications. Nord J Psychiatry.2016, 15:2,  93-102 
 
79. Basso, MR, Nasrallah HA, Olson SC, Bornstein RA. Neuropsychological 
correlates of negative, disorganised and psychotic symptoms in 
schizophrenia. Schizophr Res,  1998; 31:2, 99-111 
 
80. Wingenfield K, & Wolf OT. HPA Axis alterations in mental disorders: Impact 
on memory and its relevance for therapeutic interventions. CNS Neurosci 
Ther; 2010,   17, 714-722 
 
81. Cotter DR  Pariante CM, & Everall IP . Glial cell abnormalities in major 
psychiatric disorders: the evidence and implications. Brain Res Bull, 2001; 
55(5), 585-595. 
 
































Doctorate in Clinical Psychology 
Catherine Bois 
2018  
Childhood adversity and cognitive ability in a sample of individuals at high clinical 
risk of developing psychosis and healthy controls 
Written in Accordance with author guidelines: 
Schizophrenia Bulletin Please see Appendix A for a full outline of these guidelines)  
Keywords: Psychosis, childhood adversity, clinical high risk, cognitive ability, 












Abstract: Empirical paper 
Background 
The aim of this study was to investigate the relationship between cumulative levels 
of adverse childhood experiences (ACEs) and both global and specific cognitive 
functioning in individuals at high clinical risk (CHR) of developing psychosis. 
 
Methods 
85 individuals at CHR and 79 similarly matched healthy controls were evaluated on 
ACEs and cognitive function. Two way MANOVAs were conducted to assess the 
interactionbetween specific domains of cognitive functioning and group 
membership, whilst two way ANOVAS were run to assess the interaction between 
global cognitive ability and group membership.  
 




We found a significant interaction between group (CHR and healthy controls) and 
ACEs in the BACS composite score, F(2,143) = 7.27, p = .001.  Post hoc tests 
indicated that healthy controls with high levels of ACEs performed significantly 
better than the CHR group F(1,143) = 7.95, p <.001 partial eta squared = 0.053  
 
Conclusions 
Our results indicate that in individuals at CHR who have experienced high levels of 
ACEs score significantly lower on a global estimate of cognitive ability, compared to 
healthy controls. These findings indicate that those at CHR for psychosis may be 
particularly vulnerable to the impact of ACEs on global cognitive ability, compared 
to healthy controls, and support the importance of future investigations into 






A history of adverse childhood experiences (ACEs) is reportedly more common in 
people with established psychosis, and has been linked to an increased risk of 
developing psychosis1,,2.It has been associated with the severity of positive 
psychotic symptoms, such as hallucinations and delusions3-7 and earlier first 
admissions and more frequent hospitalisations8. It is an extensive concept that 
encompasses exposure to a range of difficult and/or unpleasant situations or 
experiences, usually before the age of 16/189,10. The adversities typically considered 
in studies of psychosis include household poverty, separation from a parent (i.e., 
family breakdown), death of a parent, neglect, abuse (including physical, sexual, and 
emotional), peer bullying, and parental psychopathology11-14 
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One proposed mechanism for the relationship between ACE and psychosis is 
through early stress operating on key neurobiological systems involved in 
generating the human stress response, such as the hypothalamic pituitary adrenal 
(HPA) axis 15,16 . Furthermore, other theories suggest that early stress affects key 
psychological mechanisms which are involved in the emergence of specific 
psychotic symptoms, such as persucatory delusions, which create an anamolous 
cognitive experienceEmerging evidence has investigated the association between 
ACEs and cognitive function in psychosis samples; however, the evidence-base is 
diverse and heterogeneous18-20. One issue of contention is whether ACE associates 
with global or specific cognitive deficits21-23, and whether this association is more 
prevalent in psychosis, compared to the typical population. At present it is unclear 
to what extent ACEs affects cognitive ability in psychosis compared to the typical 
population, as there is also evidence to suggest that it is associated with impaired 
cognitive capacity in the general population24,25  
 
A recent systematic review assessing the link between early adversity and cognitive 
ability in relation to psychosis found several limitations in the evidence that curtails 
the generalisability of conclusions that can be drawn regarding the above. In brief, 
most samples utilized patients that had had the disorder for several years; however, 
cognitive deficits have been linked to antipsychotic medication length of illness, 
chronicity of psychotic symptoms, institutionalization, prolonged substance use and 
medication, and poor physical health26-30 . Thus, it remains highly likely that some, if 
not all, existing literature is heavily confounded by these factors, which may explain 
some of the inconsistencies across studies regarding associations between cognitive 
domains and ACEs in psychosis, ability compared to controls31,32. 
 
Most of the existing literature assessing the link between cognitive ability and ACEs 
has not investigated the cumulative effect of ACEs. However, adversities tend to 
co‐occur and persist over time, often in worsening cycles of vulnerability9,33 and 
evidence is converging to suggest that multiple adversities may have an additive 
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effect on risk of developing psychosis, as well as severity of symptoms34-36. 
Understanding this link further may help elucidate information regarding 
resilience37 to psychosis, as not everyone that experiences early trauma goes on to 
develop psychosis. 
 
 In order to provide a more robust understanding regarding the link between ACEs 
and cognitive ability in relation to psychosis, as opposed to confounding factors, 
studies of individuals at clinical high risk (CHR) for developing psychosis can be 
studied, without the potential confounds of antipsychotic medication, chronicity of 
symptoms and length of illness mentioned above. In brief, CHR individuals can be 
identified when they present with “attenuated” psychotic symptoms, full-blown 
psychotic symptoms that are brief and self-limiting, or a significant decrease in 
functioning in the context of a family history of schizophrenia38 . Studies of cognitive 
function in these populations have suggested that individuals at CHR for psychosis 
may have more cognitive deficits compared to controls, and that these are 
associated with the severity of their psychotic symptoms 39-41. Only one study has 
used a clinical high risk sample to look at this association42, however this study did 
not include a control group.  Assessing the link between CA and cognitive ability in 
those at CHR has profound clinical implications, as this may provide optimal targets 
for early intervention strategies. Based on the existing literature, it is predicted that 
those at high risk would be more sensitive to the effects of ACE, compared to 
controls, in that higher levels of ACE’s will be associated with lower levels of 
cognitive functioning in those at high risk. It is also predicted that this may be 
present on a global scale, as opposed to specific cognitive domains. 
 
2.2 Materials and Methods 
 
2.2.1 The Youth Mental Health Risk and Resilience Study (YouR-study) 
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The present study draws its sample from a larger ongoing and established study: the 
Youth Mental Health Risk and Resilience Study (YOUR-Study) individuals between 
the ages of 16 to 35 were recruited, that were deemed either at high clinical risk of 
developing psychosis or to be a healthy control. Inclusion criteria for the high-risk 
sample were high risk-criteria according to the Comprehensive assessment of at-risk 
mental states (CAARMS)43 or Schizophrenia Proneness instrument (SPI-A)44, or SPI-A 
only, male or non-pregnant female >16, <35 years of age, written informed 
Consent, normal to corrected vision.  Exclusion criteria for the high risk sample were 
suicidal ideation, pregnancy, > 16, <35 years of age, metal implants in body parts, or 
an existing neurological disorder. For the controls, the inclusion and exclusion 
criteria were the same as above, without the CAARMS/SPI-A criteria, and the added 
on exclusion criteria that they did not have a 1st degree relative with a diagnosis of 
schizophrenia.  
 
The controls were recruited from a pre-existing database of Psychology students, or 
through flyers distributed at university settings and a specific webpage set up for 
the purposes of this study. The recruitment of high risk individuals also involved 
individuals from a pre-existing database of Psychology students, or through flyers 
distributed at university settings and the same specific webpage used for controls. 
NHS patient services in NHS Greater Glasgow and Clyde and NHS Lothian, NHS First 
Episode Psychosis Services, Community Mental Health Teams (CMHTs), Primary 
Care Mental Health Teams (PCMHTs), Clinical Psychology Services, Community 
Adolescent Mental Health Services (CAMHS), student counselling services, and the 
general population. Informed consent will be obtained either online through the 
website or on site by a member of the research team. Following informed consent, 
a screening questionnaire will be administered and basic demographic information 
will be obtained. If the participant endorses more than 6 items on the PQ or 3 or 
more perceptual/cognitive items, participants will be contacted per 
telephone/email by a member of research team. A first visit will then be scheduled. 
After informed consent is obtained during which the positive scale of the 
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CAARMS/SIPS-Interview will be administered to establish ultra high risk criteria. In 
addition, information about family history, drug abuse and demographic 
information will be obtained. 
 
Thus, the present study utilized a total of 85 individuals that met high risk criteria, 
and 79 controls that had a full neuropsychological profile and measures of adverse 
childhood experiences. All measures were administered by trained research 
assistants, receiving supervision by senior medical professionals. If anybody was 
distressed or suicidal during the assessments, the questions were discontinued and 
appropriate referrals to crisis services or referrers made. 
 
2.2.2  Ethical Procedure  
The YouR-Study was performed according to the Research Governance Framework 
for Health and Community Care (Second edition, 2006) and the study has 
appropriate REC approval from the west of Scotland research ethics committee and 
then has local R&D approval from NHS Lothian and NHS greater Glasgow and Clyde, 





2.3.1 Neuropsychological assessments 
The brief assessment of cognition in schizophrenia (BACS) is an instrument that was 
specifically developed with the intention to assess aspects of cognition that have 
been found to be the most impaired and strongly correlated to outcome in 
schizophrenia31. It assesses five different domains of cognitive function with six 
tests, which can also be combined to provide a more general, “composite” score of 
cognitive ability, which has been previously highly linked to functional outcome in 
psychosis45. The BACS takes approximately 30-35 minutes to complete in patients 
with schizophrenia and is a well-validated and portable instrument with high 
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reliability, and has been shown to be as sensitive to cognitive impairment in 
patients as a standard battery of tests that required over 2 hours to administer45-47. 
The following tests were administered as noted in the BACs manual from where the 
test explanations are extracted45: 
 
2.3.1.1 Verbal Memory  
Assessed with 5 trials of list learning, whereby individuals are presented with 15 
words and then asked to recall as many as possible, with the main measure being 
the number of words recalled per trial, in any order (range 0-75).   
2.3.1.2 Working Memory 
Individuals were presented with clusters of numbers that increased in length, and 
required to tell  the numbers in order, from lowest to highest, with the main 
measure being the number of correct responses (range 0-28). 
2.3.1.3 Motor Speed 
This was assessed with a token motor task, whereby individuals were given plastic 
tokens and asked to place them two at a time into a container as quickly as possible. 
A 60 second time limit was imposed, and the number of tokens correctly placed into 
the container was the main measure.  
2.3.1.4 Verbal Fluency 
Category Instances 
Patients were given 60 seconds to name as many words as possible within a given 
category. Version A: supermarket items; Version B: tools. 
Controlled oral word association test 
In two separate trials, patients were given 60 seconds to generate as many words as 
possible that begin with a given letter. Version A: F, S; Version B: P, R Measure: 
number of words generated per trial. 
 
2.3.1.5 Attention and speed of information processing 
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Symbol coding. As quickly as possible, patients wrote numerals 1 –9 as matches to 
symbols on a response sheet for 90 seconds. Measure: number of correct numerals 
(range: 0 –110) 
2.3.1.6 Executive Function 
Tower of London adapted task in which the main outcome measure: number of 
correct responses (range: 0 – 22). 
 
2.3.2 Adverse Childhood Experiences Measures  
The method for assessing childhood adversity experiences was adapted from a 
previously validated method48. For the exact questions included in this inventory, 
please see Appendix H. In brief, it is a scale that is adapted from several pre-existing 
scales: Conflict Tactics Scale49, the Wyatt questions on sexual abuse50   and the Child 
trauma questionnaire 51. The ACEs questionnaire demonstrates excellent test–retest 
reliability, internal consistency (Cronbach’s a = .95), and construct validity52, 53. All 
questions relate to the individuals eighteen first years of life. The questions pertain 
to any experiences of: physical, sexual, emotional abuse, emotional and physical 
neglect. Five types of dysfunction of household are also assessed: mental illness, 
domestic violence, parental separation or divorce, substance abuse, and criminal 
behaviour in the household. Participants rated their exposure to ACEs as “never, 
once or twice, sometimes, often, or very often”. If they answered that the type of 
ACE occurred at least once, then they were considered to have been exposed to 
that ACE. 
 
2.3.3 Assessment of Psychosis/At Risk Mental States 
The CAARMS is a semi-structured interview schedule to be used by qualified mental 
health professionals43. It has been used reliably in several clinical high risk studies55-
57  .It includes assessment of subthreshold positive symptoms such as: disorders of 
thought content (such as overvalued ideas and delusions), perceptual abnormalities 
(such as hallucinations), conceptual disorganization (such as objective assessment 
of formal thought disorder).  






2.4 Statistical Analysis 
 
2.4.1 Analysis Regarding Group Effects on Cognitive Ability in Relation to Number 
of ACEs experienced 
All statistical analysis was conducted with SPSS (version 23).  As in Dube48 the total 
number of exposures (range: 0–10) was summed to create a cumulative AC 
experience score for each participant. ACE scores of 3 or more were combined into 
one category reflecting a high level of ACE in accordance with previous studies48,50, 
and a factor with three levels was created: no ACE’s reported, low levels of ACE’s 
reported, and high levels of ACE’s reported. 
 
The primary scores for each BACS subtest were transformed into z-scores whereby 
the mean for healthy control subjects was set to 0 and the standard deviation (SD) 
to 1. Composite score for global cognition was generated by transforming the mean 
of all six BACS z-scores to standardized values, with reference to the normative 
mean for the healthy control subjects as 0 and the SD as 143.  
 
Firstly, a two-way ANOVA with the interaction between Group (High Risk and 
Controls) and number of ACEs (none, low, high) as the independent variable, and 
the standardized BACs score composite as the independent variable were run, with 
relevant confounding factors entered and removed if they did not significantly 
improve the model’s fit. A two-way MANOVA with the interaction between Group 
(High Risk and Controls) and number of ACEs (none, low, high) as the independent 
variable, and the z-scores of the six sub tests of the BACS entered as our dependent 
variables was conducted (verbal memory, working memory, motor speed, verbal 
fluency, attention and speed of information processing, executive function). All 
underlying assumptions for the ANOVA and MANOVA were checked before 
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proceeding, and any necessary transformations conducted. Any significant 
interaction effects were followed up with simple main effects analysis and post-hoc 
testing, Bonferroni corrected for multiple comparisons throughout. 
 
Relevant demographic variables were also compared between those at high risk and 
the control group, as well as across the different levels of the ACE variable, with X2  





























Sample Demographics are shown in Table 1 and 2.  A significant difference emerged 
between high risk and controls in number of years in education, F(1,149) = 5.40, p = 
.021 and medication, F(1,161) = 22.8, p <. 000. No other demographic variables 
differed significantly between the groupings (Appendix I). 
 
 
Table 1. Relevant Demographics for the different groups (controls versus high risk), 
levels of ACE (none,low,high).  
 Controls (n = 78) High Risk (n = 85) 
Sociodemographic    
Age (years), mean (SD) 23.1(4.24) 22.1(4.34) 
Education (years), mean (SD) 16.4(3.07) 15.2(3.20) 
Gender (M/F) (28/50) (21/64) 













Table 2. Relevant Demographics for levels of ACE (none,low,high).  
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 None (n = 55 ) Low (n = 64 ) High (n = 35 ) 
Sociodemographic     
Age (years), mean (SD) 22.4(3.83) 22.4(4.19) 23.1(5.32) 
Education (years), mean (SD) 16.0(3.09) 15.8(3.15) 15.5(3.47) 
Gender (M/F) (18/42) (23/45) (8/27) 
Premorbid IQ (NART) 112(8.28) 114(10.8) 110(9.36) 
 
2.5.2 Relationship between level of ACEs and specific cognitive domains in 
Controls versus CHR 
 
All parametric assumptions of a two way MANOVA were checked and appropriate 
transformations applied (Appendix J).. There was no significant main effect of either 
group (p = .335), nor level of ACE (p =.499) on the combined effect of all different 
BACS domain scores. There was no significant interaction effect between group and 
level of ACES on the combined effect of all different BACS domain scores, F(6,278) =  
1.49,,  Wilks' Λ = 1.49, p = .128, partial η2  = .061. Breakdown of prevalence rates of 
the different ACEs across the different groupings and ACE levels are summarised in 
Table 3. Raw mean scores of the different cognitive domains and the total BACS 




Table 3. Prevalence rates of the different ACEs in the CHR and control groups 
 
 
Prevalence(yes)   
 Controls(n =79) High Risk Sample 
total (n = 88) 
Total (n 
=67) 
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Abuse (yes)    
 Emotional 8 (10.1%) 21(24%) 29(17%) 
 Physical 3(3.8%) 5(6%) 8(5%) 
 Sexual 6(7.6%) 11(13%) 17(10%) 
Neglect (yes/no)    
 Emotional 6(7.6%) 16(18%) 22(13%) 
 Physical 0(0%) 10(11%) 10(6%) 
Household  dysfunction yes/no)    
 Battered mother 2(2.5%) 10(11%) 12(7%) 
 Parental separation or 
divorce 
19(24.1%) 32(36%) 51(31%) 
 Mental illness in 
household 
20(25.3%) 41(47%) 61(37%) 
 Household substance 
abuse 
11(13.9%) 23(26%) 34(20%) 
 Incarcerated household  
member 
1(1.3%) 6(7%) 7(4%) 
ACE score    
 0 38(48%) 23(26%) 61(36.5%) 
 1 20(25%) 26(30%) 46(28%) 
 2 12(15%) 12(14%) 24(14%) 
 3 4(5%) 8(9%) 12(7%) 
 4 4(5%) 6(7%) 10(6%) 
 >5 1(1%) 13(15%) 14(8%) 
 
 
Table 4. Raw mean scores of the different cognitive domains and the total BACS 
score are presented in 
 None Low High Total 
Verbal Memory total score     
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(verbal memory & learning) 
Controls  51.9(1.65) 50.1(1.79) 57.4(3.39) 51.8(9.67) 
High Risk 48.7(2.12) 54.2(1.65) 47.2(1.2) 50.6(11.0) 
Digit Sequencing (working 
memory) 
    
Controls 21.3(3.33) 20.9(3.14) 22.6(2.00) 21.28(3.14) 
High Risk 20.4(3.70) 21.5(4.79) 19.4(2.82) 20.6(4.04) 
Token Motor (motor function)     
Controls 80.5(15.5) 76.9(18.7) 76.3(15.1) 78.6(16.8) 
High Risk 76(15.9) 71.3(18.1) 65.0(16.5) 70.6(17.4) 
Semantic Fluency (verbal 
fluency) 
    
Controls 56.3(12.4) 55.3(12.4) 63.3(10.9) 56.7(12.3) 
High Risk 54.8(13.9) 60.2(12.2) 54.9(11.4) 57.2(12.5) 
Symbol coding (speed of 
processing) 
    
Controls 75.9(12.8) 70.2(12.9) 73.3(9.99) 73.3(12.7) 
High Risk 69.0(15.9) 69.5(13.6) 62.2(11.4) 67.2(13.9) 
Tower of London (executive 
function) 
    
Controls 18.8(1.7) 18.0(2.20) 18.7(2.96) 18.5(2.01) 
High Risk 18.04(2.79) 18.8(1.83) 17.5(2.42) 18.2(2.34) 
Mean Total BACS score     




Controls 303(28.7) 289(31.2) 305(19.8) 297(2.5) 
High Risk 281(44.8) 295(32.8) 263(33.3) 281(38.5) 
 
2.5.3 Relationship between level of ACEs and BACS total composite score in 
Controls versus CHR 
 
All assumptions required for two-way ANOVA were checked and upheld (Appendix 
K). There was a significant effect of group on the BACS composite score,(F (1,157) = 
8.21, Wilks' Λ = 1.92, η2= 0.050, p = 0.005, and analysis of means showed that this 
was because those at high risk (m = -.160, sd = .844) had  significantly lower BACS 
composite scores compared to controls (m  = .175, sd =  .845). There was no 
significant main effect of ACE  (p = .795) on BACS composite score. A significant 
interaction effect emerged between group and level of ACES in the composite BACS 
score, F(2,143) = 7.27, p = .001, Wilks' Λ = 1.98  partial η2  = .092. This interaction 
effect was followed up by analysis of simple main effects and post-hoc testing, 
controlled for multiple comparisons, (Bonferroni), which showed that when controls 
and those at high clinical risk with a high level of ACEs were compared, mean 
composite BACS scores was 1.098 points higher in controls, compared to the CHR 
group (95% CI = ,-1.65 - .422) ), F(1,143) = 7.95, p <.001 partial eta squared = 0.053. 
This is illustrated in Figure 2. 




Figure 2. Clustered bar chart showing differences in standardized z scores for BACS 
composite score (y-axis) between controls (blue) and the clinical high risk group 





2.6.1 Summary of Main Findings 
To summarise, we investigated whether there was any association between the 
number of ACEs experienced and group membership (clinical high risk versus 
control) in any of the BACS subdomains, as well as the composite score, indicative 
of global cognitive ability. We found higher levels of ACEs in the high-risk sample, 
which is consistent with previous research59,60. We found that although there was 
no significant interaction effect between levels of ACEs and group membership in 
relation to the specific cognitive domains, there was a significant interaction effect 
in relation to the BACS composite score, in that those at high risk had significantly 
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lower BACs composite scores, compared to healthy controls, when having 
experienced a high level of ACEs. 
 
Intriguingly, we did not find that the relationship between number of ACEs and 
symptom severity/distress as measured by the CAARMS was mediated by the BACS 
composite cognitive score in the high risk sample. To our knowledge, the present 
study is the first to investigate the cumulative effect of number of ACEs on global 
cognition in a sample of high risk individuals, as well as assess to what extent this 
relationship was also present in a healthy control group. 
 
2.6.2 Clinical Implications 
Increasingly, evidence is pointing towards the heterogeneity of psychosis and the 
lack of one underlying causal factor. In particular, evidence is pointing towards the 
underlying brain pathology being widespread in nature, rather than linked to 
isolated brain regions61-63. Thus, the research indicating that global estimates of 
cognitive ability are affected may better able to capture these widespread 
perturbations, and this study indicates the importance to continue to assess more 
general cognitive ability, as opposed to just specific domains in relation to the high-
risk state, in order to not obscure important global effects in cognitive ability.  
 
Our findings suggest that an increased level of ACES in those at high risk of 
developing psychosis is associated with a lower cognitive score compared to healthy 
controls. This has important clinical implications, as understanding the 
developmental trajectory of the high risk state, compared to typical development, 
can grant us unique insight into developing psychopathology and individual 
differences in risk and resilience. As early intervention has been consistently 
associated with improved prognosis in psychosis 64-66 our results indicate that 
efforts aimed at ameliorating early ACEs may have a critical impact on those who 
subsequently go on to have attenuated psychotic symptoms, by potentially 
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protecting estimates of global cognitive ability, thus potentially offering a target for 
resilience strategies. Our results should provide evidence for the importance of 
lobbying for childhood adversity prevention programmes, or attempting to reduce 
the number of ACEs by early identification of children exposed to early adversities.  
Previous studies that have used environment enrichment programme for children 
between the age of 3 to 5 showed that this was associated with a reduced number 
of schizotypal traits in early adulthood.67,68 
 
Clinically, our results are important, as there remains reluctance on the part of 
mental health services to routinely inquire about trauma, potentially due to 
concerns about offending, or distressing the individual concerned69-73. Furthermore, 
cognitive therapy based on the understanding of early ACEs may provide a further 
key intervention strategy aimed at preventing transition to psychosis in high-risk 
samples, as time since the trauma is not a predictor of treatment outcome in 
trauma-focused approaches73-76. We may also be able to reduce the impact of the 
psychological sequelea of ACEs and the impact they may subsequently have on 
symptoms by formulating on trauma, as opposed to just distress. As individuals with 
psychosis that have a background of adversity also have greater health care 
utilization and poorer psychosocial outcomes79,80  future research may benefit from 
looking at how these outcomes combine with ACE an cognitive ability, rather than 
just estimates of  symptom distress or severity and assess the relationship between 
ACEs and cognitive ability.  
 
2.6.3 Limitations  
One limitation of present study is that the childhood adversity measure we utilized 
did not assess the impact of the trauma on the individual in terms of asking how 
traumatic it was for the individual.  For example, early adversity such as sexual 
abuse, seems to be particularly implicated in auditory verbal hallucinations but less 
so in paranoid delusions85,86. It has been suggested that trauma may link with 
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cognitive vulnerability to psychosis by contributing to negative cognitive schema, 
whereby individuals perceive themselves as powerless and others as threatening 
and subsequently the world as unsafe85,86, and this may be important for future 
studies to consider. 
 
Another limitation of this study is that we did not look into the specificity of 
psychotic symptoms as opposed to other symptoms, such as PTSD/comorbidity, 
interpersonal factors, and/or attachment, which may moderate or mediate the 
relationship between CT and cognitive ability in psychosis87. Psychological mediators 
such as emotional intelligence, shame, and alienation will be crucial for future 
investigations to assess. Additionally, it is important to note also that the BACS total score 
may have limited validity and reduce important individual variability across sub-domains of 
cognitive functioning.  Furthermore, we did not assess to what extent early adversity 
was confounded by socio-economic status or low intelligence of parents/household 
members, which future studies may want to do. 
 
 Another limitation is our measure of cumulative ACEs, which assumes a linear 
effect of ACEs.  By simply adding the number of exposures, we are assuming that 
each has an equivalent effect, which is unlikely to be the case, and the possibility 
that there are threshold effects has not been considered88. Some studies of 
abnormal HPA axis in patients with psychotic disorders irrespective of early trauma 
and evidence of systemic cortisol metabolism with links to genetic markers in 
psychosis89,90 also exist, and we did not assess the extent to which this may interact 
or influence our cumulative measure of adversity. Indeed, recent research has 
utilized a threshold model whereby both genetic and environmental factors  such as 
childhood adversity, cannabis use, urbanicity, foreign born, hearing impairment, and family 
history of affective disorders, interact and indicated an additive effect of these in that 
the greater the number of risk factors, the greater the odds of psychotic experiences91. 
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Furthermore, although we showed a different effect of high levels of adversity in 
those at high risk compared to psychosis, we did not include other controls, such as 
first episode psychosis, or include individuals with other mental health conditions, 
such as depression. As many children are exposed to adversity and do not develop 
psychotic disorders or experiences, future research is required to assess the link to 
other negative mental health outcomes, such as depression and substance abuse. 
Furthermore, our controls consisted of mostly university students, and both of our 
groups indicated a relatively high premorbid IQ and years of education, and future 
studies with perhaps more representative samples of the population may be 
required to generalize our finding.  
 
2.6.4 Summary and Conclusions 
Our findings suggest that the impact of high levels of ACEs on global cognitive ability 
may be particularly associated in those at clinical high risk of developing psychosis, 
compared to healthy controls, and that this may be mediated by another aspect of 
vulnerability to psychosis as opposed to psychotic symptom distress/severity. Our 
findings have important clinical implications and indicate the importance of 
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Appendix B. Search strategy and databases covered for systematic review 
Electronic database searches yielded 1051 results with 814 remaining following the 
exclusion of duplicates.  The first screening wave consisted of reviewing titles only, 
and this resulted in the exclusion of 419 titles. The second wave involved reviewing 
abstracts too, and this excluded a further 177 references. At this point 43 papers 
were reviewed in more depth, and at this stage 22 further studies were excluded as 
they did not meet the criteria of either being primary research, no measure of 
psychotic symptomology, no measure of trauma and/or cognition. A further 2 
studies were found by hand searching the reference lists at this stage. Total of 18 
included for the study.  
Categories covering psychosis and cognitive ability within databases was 
implemented where possible to ensure a comprehensive search of the available 
literature, and identified using the following search terms “cognitive ability*” or 
cognition or neuropsychol* or “neuro* assessment*” or “cognitive assess*” AND 
 (pathway* or associat* or or “mechanism*” mediat* or variable* or relation* or 
"risk *", “predictor”) AND “child abus*” “child traum*” “physical abus*” “sexual 
abus*” “rape*”  “psychological abus*” “emotional abus*” “neglect*” “maltreat*” 
“bully” “bullied” “victim*” “sexual trauma*” “psychological traum*” “physical 
assault*” “sexual assault*” “molest*”   AND (psychos* or schiz* or hallucinat* or 
paranoi* or voice* or delusion* or prodrom* OR  high risk).“psychological distress”  
  
Databases searched were Pubmed/Medline, PsychArticles full text, EMBASE, 
EMBASE classic, Global Health, Epub ahead of print and other non-indexed citations. 
Web of Science and Proquest were also searched to see if any further articles 
emerged, however they did not. Additional articles were identified following 
examination of reference lists from primary search results to ensure, as much as 
possible, that all pertinent studies were included.  
 
 
Doctorate in Clinical Psychology 
Catherine Bois 
2018  
Appendix C Table of 14 quality criteria used to grade each paper 
Gradings allocated 2 points if deemed well-covered , 1 point if partially addressed , 




Criteria Description Grading  




2 Well covered relevant background 
literature discussed and rationale for 
present study clearly understood 
1 Partially covered and rationale 
explained 
0 Background literature not clearly 
stated 
2 Does the study question 
address a clear and 
appropriate question with 
appropriate hypotheses? 
 
2 clearly stated and directional if 
appropriate  
1 partially stated/not directional 
0 not stated at all 
3 Population-clearly described 
and justified? Eg adequate 
inclusion/exclusion criteria 
 
2 Well-covered inclusion and 
exclusion criteria stated 
1 Partially covered  
0 Inclusion criteria/exclusion criteria 
not mentioned, inadequately 
mentioned  
4 Was the sample 
representative of the 
population? E.g. sampling 
methods, setting, age range, 
gender, consider how many 
invited took part. 
 
2 Well-covered confident in 
generalizability, multiple setting 
recruitment, good balance of age, 
gender etc 
1 Somewhat representative but not 
optimal 
0 very specific population  
5 Power calculation for sample 
included? 
 
2 Power calculation provided  
1 Power calculation provided from 
other paper 
0 No power calculation reported 
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6 Were standardised measures 
of childhood trauma 
mentioning validity and 
reliability mentioned? 
 
2 Well covered validity and reliability 
mentioned as appropriate for different 
measures (eg childhood trauma) 
1 Partial: covered validity and 
reliability mentioned for some 
measures 
0 no mention of validity and reliability 
7 Were the cognitive variables 
measures reliable and valid? 
2 Present: Standardised and well-
normed measures, good reliability 
and validity  
1 Partial: Compromised in any area 
above 
 0 Absent: No standardised measure 
specific to cognitive variable(s) used 
8 Were known confounding 
factors measured and 
accounted for in the analysis? 
Eg gender, iq, length of 
illness, antipsychotic 




2 Present: Thoroughly measured and 
accounted for  
1 Partial: Some mentioned and 
somewhat accounted for 
0 Absent: Not measured. Or 
measured but not accounted for in 
analysis 
9 Are the analysis methods 
appropriate? In particular, 
multiple comparisons 
adequately controlled for 
 
2 Present: The analysis is appropriate 
for the study design and the collected 
data 
1 Partial: Could be better  
0 Absent: The analysis used is 
inappropriate for the study design 
and/or data 
10 Were effect sizes and 
confidence intervals cited for 
reported associations cited? 
 
2 Present 
1 Partially present 
0 Not mentioned at all, not covered at 
all 
11 Overall results-clearly and 
logically explained? 
 
2 well covered 
1 partially covered 
0 poorly covered, not covered at all 
12 Wider implications discussed 2 well covered 
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 1 partially covered 
0 poorly covered, not covered at all 
13 Findings compared to other 
studies and discrepancies 
addressed 
 
2 well covered 
1 partially covered 
0 poorly covered, not covered at all 
14 Limitations addressed 
 
2 well covered 
1 partially covered: but some 
essential limitations not mentioned 







































Appendix E Table of extracted demographics from relevant studies, adapted from 
the reviewed studies 






Sample (N) Relevant 
Demographi
cs of Sample 
























schizophrenia based on 
the criteria of the 
Structured Clinical 
Interview for DSM-IV 
(SCID) ,in a stable clinical 
condition, age between 
16 and 65 years, ability 
to sign the consent form, 
IQ above 80  on the 
WASI 
Exclusion criteria: 
Patients were excluded if 













P = 617 















Inclusion criteria:  
control participants had 
no personal history of 
DSM-IV Axis 1 disorder, 
and no history of 




Exclusion criteria : 
inability to converse 
fluently in English, 
organic brain disorder, 
brain injury with greater 
than 24 h post-traumatic 
amnesia, (IQ < 70), 
movement disorders, 
current diagnosis of 
substance dependence, 
and/or electroconvulsive 
therapy received in the 























Sample (N) Relevant 
Demographi
cs of Sample 





















patients N = 
1059 
 




































patients: age range 16-
50 (extremes included), 
diagnosis of non-
affective psychotic 
disorder according to 
DSM-IV.  
For siblings: same as 
above. For controls: 
same as above but also 
no lifetime psychotic 
disorder, no first degree 
family member with a 
lifetime psychotic 
disorder.  
Co morbidity in patients 
and siblings was not an 
exclusion criteria. When 
siblings had a lifetime 
psychotic disorder they 
were included in the 













Sample (N) Relevant 
Demographi
cs of Sample 


























HC  = 24(4.8) 










Inclusion Criteria: Early 
psychosis patients were 
subjects with a PD less 
than 3 years from the 
onset of the illness. 
 
 Exclusion criteria: 
Pregnancy, learning 
disaiblity, severe head 





(other than tobacco or 
cannabis), language 
difficulties or visual 
impairment that limited 
the administration of the 
cognitive battery. 
Doesn’t state for control 
group, except screened 






































None stated but says 
part of larger TOP study 























Sample (N) Relevant 
Demographi
cs of Sample 














P = 100 Age(Mean/s
d): 
Male CPA+ = 
31.6(9.8) 
Male CPA-  = 
30.9(7.7) 
Women 





























Mean = 45 









None stated, except for: 
 
Inclusion criteria SCID 
confirmed DSM IV 
diagnoses of 
schizophrenia (n = 31) or 
schizoaffective disorder 















































Sample (N) Relevant 
Demographi
cs of Sample 














83 FEP, 63 
HC 
 





















presented for the first 
time to the local 
psychiatric services with 
a functional psychotic 
illness (ICD-10 F10–19, 
over a 3-year period. 
 
Exclusion criteria were 
(a) history of head 
trauma resulting in loss 
of consciousness for over 
1 h; (b) presence of a 
disease of the central 
nervous system; (c) 
moderate or severe 
learning disabilities as 
defined by ICD-10 
(World Health 
Organisation, 1992a); (d) 
poor fluency in English 
language; and (e) 
transient psychotic 
symptoms resulting from 
acute intoxication as 











































Sample (N) Relevant 
Demographi
cs of Sample 






















































Diagnoses were based 
on DSM-IV criteria, using 
the Comprehensive 
Assessment of 
Symptoms and History 
(CASH) interview 
 The CASH was 
additionally used to 
confirm the absence of 
non-affective psychosis 
in siblings  
Exclusion criteria brain 
injury with loss of 
consciousness >1 hour,  
meningitis/other 
neurological diseases,  
cardiac arrhythmia,  
severe claustrophobia, 
Vmetal corpora aliena 
(including intrauterine 
devices) VI) ,pregnancy.  
 CTQ, 
25 item  
Outpatie















































apist made diagnosis 
upon admission: 
participants met criteria 
of a diagnosis of 
schizophrenia 76.2%, 
schizoaffective disorder 
10.7%, and acute 
polymorphic psychotic 
disorder 13.1%. Ninety-
five individuals with 
psychosis were admitted 






























Sample (N) Relevant 
Demographi
cs of Sample 












l et al. 
2005 








None clearly stated, 
exclusion criteria. 
All subjects met DSM-IV 
(American Psychiatric 
Association, 1994) 
criteria for schizophrenia 
(n = 21) or 
schizoaffective disorder 
(n = 19) and gave 
informed consent to 

























e et al. 
2012 
P = 408 








P = 34% 
HC = 57% 
Country: 
Australia 
Inclusion criteria:  aged 
18 – 65 years. 
 
Exclusion criteria:  
 
Participants are English 




 Exclusion criteria are 
organic brain disorder, 
brain injury with greater 
than 24 hours post-
traumatic amnesia, (IQ 
<70 70), movement 
disorders, current 
diagnosis of substance 
dependence, 
electroconvulsive 
therapy received in the 
last 6 months and, for 
controls, a personal or 
family history of 































Sample (N) Relevant 
Demographi
cs of Sample 






















criteria to identify 
individuals at UHR (Yung 




mental retardation, prior 
antipsychotic treatment, 
severe medical 
condition, prior history 
of psychosis that lasted 
more than a week, and 


























n et al. 
2011 





None Clearly stated. 
SM-IV diagnoses were 
reached by consensus 
after case note review 
and discussion between 
the responsible 
psychiatrist and his 
colleagues. A total of 90 
patients fulfilling 
diagnostic criteria were 
approached and 85 
people gave written 
consent to participate 
after a complete 
description of the study 
was provided. Of those 
85, 67 were male and 18 



















Sample (N) Relevant 
Demographi
cs of Sample 



















HC = 52 
P Mean(SD) 





P = 25%, 





Inclusion criteria: aged 
16–45 years; 
experiencing a first 
psychotic episode; and 
meeting DSM-IV TR 
(Diagnostic and 
Statistical Manual of 
Mental Diseases, Fourth 
Edition, Text Revisions) 
We assessed patients 
with the Structured 
Clinical Interview for 
DSM-IV [SCID] (First et 
al. 2002). 
Exclusion criteria : a 
lifetime exposure to 
antipsychotic medication 
for longer than 4 weeks; 
any serious general 
medical condition; 
obvious current 
substance abuse; and an 
educational level of 
lower than Grade 7. A 
group of healthy 
controls, matched for 
age, gender and 
ethnicity were recruited 
from the same 
catchment area as the 
patient group through 
personal contacts and 
advertisements. 
Controls were excluded 
if they had an 
educational level of 
lower than Grade 7 and 
if they had a psychiatric 
disorder as identified 
























Sample (N) Relevant 
Demographi
cs of Sample 














P = 617 








































































Sample (N) Relevant 
Demographi
cs of Sample 













































Cases were individuals 
aged 18 to 65 at their 
first admission fulfilling 
ICD-10 criteria for 
psychosis (F20-29 or F30-
34); subjects with severe 
learning disability (IQ < 
50), poor English fluency, 
or a known organic 
cause for their psychosis 
were excluded. Controls 
were recruited from the 
same catchment area as 
cases and screened for 
current or past psychotic 
disorders using the 
Psychosis Screening 






















































Sample (N) Relevant 
Demographi
cs of Sample 

















P = 47% 
HC = 54% 
UK 
Inclusion criteria: 
Diagnoses were made 
according to ICD-10 
criteria individuals aged 
16–65 years were 
approached, who 
consecutively presented 
for the first time to the 
local psychiatric services 
of South-East London for 
a functional psychotic 
illness (ICD-10 F10-19,  
(excluding coding F1x.0 
for Acute intoxication; 
F20-29 and F30-39, 
psychotic codings; over a 
3-year period 
Exclusion criteria: 
History of head trauma 
resulting in loss of 
consciousness for over 1 
h, the presence of a 
disease of the central 
nervous system, 
moderate or severe 
learning disabilities as 
defined by ICD-10 ,poor 
fluency in English 
language; transient 
psychotic symptoms 
resulting from acute 
intoxication as defined 
by ICD-10). As the focus 
of the current study was 
on cognitive function in 
schizophrenia and 
affective psychoses 
(bipolar and affective 
depression), patients 
with brief and transient 
psychosis were excluded. 
Controls were screened 
using the Psychosis 
Screening Questionnaire, 
exclude if present or 
past psychotic disorder 






























































Appendix F  Quality ratings utilizing the quality criteria for each reviewed paper 
 Quality Criteria Overall 
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Authors 1 2 3 4  
5 
6 7 8 9 10 11 12 13 14 Score 
Li et al. 2017 1 0 1 1 0 2 2 0 1 1 1 1 1 0 11 
Van Os et al. 
2017 
1 2 1 2 0 0 1 2 2 2 2 2 1 0 18 
Garcia 
 et al. 2016 
1 1 2 1 0 1 1 1 1 0 2 2 2 2 17 
Ukok  
et al. 2016 
1 2 2 1 0 2 1 1 1 0 1 1 1 1 15 
Sideli 
 et al. 2014 
2 2 1 1 0 1 1 0 1 0 2 2 2 1 16 
Aas  
& Steen et al. 
2012 
2 1 1 1 0 2 1 1 2 0 2 2 2 2 19 
Lysaker et al. 
2001 
1 2 0 1 0 0 1 1 2 0 2 1 0 1 12 
McCabe 
 et al. 2012 
2 2 1 1 0 0 2 2 2 0 2 1 2 2 19 
Schalinski et 
al. 2018 
1 1 1 1 0 2 2 2 2 2 2 2 1 1 20 
Kelly 
 et al.  
2016 
2 1 0 1 0 2 1 1 2 0 1 2 1 2 16 
Kilian et al. 
2017 
2 1 2 1 0 2 2 1 1 0 2 1 1 2 18 
Aas 
 & Dazzan et 
al. 2011 
2 2 2 1 0 2 2 1 1 0 2 2 2 2 21 




 et al. 2011 
1 1 0 1 0 0 1 1 2 2 2 2 2 2 17 
Schenkel et al. 
2005 
2 2 1 1 0 0 1 0 1 0 2 2 2 2 16 
Green 
 et al. 2015 
2 1 2 2 0 1  1 1 1 1 2 1 2 2 19 
Green et al. 
2014 
2 2 2 2 0 1 2 0 1 0 2 1 1 2 18 
Hernaus et al. 
201 
2 1 2 1 0 0 1 2 2 1 2 2 1 2 19 
Aas 
 & Navari et 
al. 2012 
















Appendix G. Full Youth and Mental Health Study Resilience Protocol 











Running title: YouR-Study 
Protocol Version: 4.0 
Date: 19.122015 
REC Reference Number: 14-WS-0099 Sponsor’s Protocol Number: GN13CP220 
Sponsor: NHS Greater Glasgow & Clyde 






Amendment number Date Protocol version 
Amendment 01 05 August 2014 Version 2.0 
Amendment 02 24 October 
2014 
Version 3.0 
Amendment 03 19 January 
2015 
Version 4.0 
   
 
 
This study will be performed according to the Research Governance 
Framework for Health and Community Care (Second edition, 2006) and 
WORLD MEDICAL ASSOCIATION DECLARATION OF HELSINKI Ethical 
Principles for Medical Research Involving Human Subjects 1964 (as 
amended).
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> 35 years of age 
Metal implants in body parts 
Pregnancy 
 
suicidal   ideation Exclusion 
criteria (controls) 
An existing neurological disorder 
> 35 years of age 
Metal implants in body parts 
Pregnancy 




Time-Frequency Analysis, Cluster-based test statistics for MEG- 
Signals, Information theoretical analysis 
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GLOSSARY OF TERMS 
Gray-Matter: is a major component of the central nervous system, 
consisting of neuronal cell bodies, neuropil (dendrites and myelinated 
as well as unmyelinated axons), glial cells (astroglia and 
oligodendrocytes) and capillaries. Grey matter is distinguished from 
white matter, in that grey matter contains numerous cell bodies and 
relatively few myelinated axons, while white matter is composed 
chiefly of long-range myelinated axon tracts and contains relatively 
very few cell bodies. 
 
Diffusion Tensor Imaging (DTI): allows the mapping of the diffusion 
process of molecules, mainly water, in biological tissues, in vivo and 
non-invasively. Molecular diffusion in tissues is not free, but reflects 
interactions with many obstacles, such as macromolecules, fibers, 
membranes, etc. Water molecule diffusion patterns can therefore 
reveal microscopic details about tissue architecture, either normal or in 
a diseased state. 
 
Magnetic Resonance Imaging (MRI): is a medical imaging technique 
used in radiology to investigate the anatomy and function of the body 
in both health and disease. MRI scanners use strong magnetic fields 
and radiowaves to form images of the body. The technique is widely 
used in hospitals for medical diagnosis, staging of disease and for 
follow-up without exposure to ionizing radiation. 
 
Magnetic Resonance Spectroscopy (MRS): is a specialised 
technique associated with magnetic resonance imaging (MRI). MRS 
is a non-invasive ionizing radiation free analytical technique that has 
been used to study metabolic changes. 
 
Neural Synchrony: A neuronal synchrony measure is a number that 
quantifies the level of synchrony of a large population of neurons 
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within a network. It is usually normalized to be between 0 and 1. It is 
equal to 0 when the neurons in the population fire in an asynchronized 
manner, it is equal to 1 when all those neurons fire in full synchrony, 
exactly at the same times, and it is between 0 and 1 for partially 
synchronized states, i.e., states in which the firing times of the neurons 
are related (synchronized) but not identical (fully synchronized). 
 
Magnetoencephalography (MEG): a functional neuroimaging 
technique for mapping brain activity by recording magnetic fields 
produced by electrical currents occurring naturally in the brain, using 
very sensitive magnetometers. Arrays of SQUIDs (superconducting 
quantum interference devices) are currently the most common 
magnetometer, and SERF being investigated for future machines. 
Applications of MEG include basic research into perceptual and 
cognitive brain processes, localizing regions affected by pathology 
before surgical removal, determining the function of various parts of 
the brain, and neurofeedback. 
 
Neural Oscillations: Neural oscillation is rhythmic or repetitive neural 
activity in the central nervous system. Neural tissue can generate 
oscillatory activity in many ways, driven either by mechanisms localized 
within individual neurons or by interactions between neurons. In 
individual neurons, oscillations can appear either as oscillations in 
membrane potential or as rhythmic patterns of action potentials, which 
then produce oscillatory activation of post- synaptic neurons. At the 
level of neural ensembles, synchronized activity of large numbers of 
neurons can give rise to macroscopic oscillations, which can be 
observed in the electroencephalogram (EEG). Oscillatory activity in 
groups of neurons generally arises from feedback connections between 
the neurons that result in the synchronization of their firing patterns. 
The interaction between neurons can give rise to oscillations at a 
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different frequency than the firing frequency of individual neurons. 
 
White Matter (WM): White matter is one of the two components of 
the central nervous system and consists mostly of glial cells and 
myelinated axons that transmit signals from one region of the 
cerebrum to another and between the cerebrum and lower brain 
centers. White matter tissue of the freshly cut brain appears pinkish 
white to the naked eye because myelin is composed largely of lipid 






Schizophrenia (ScZ) is the most severe manifestation of psychosis and is recognised 
as a debilitating mental illness with a lifetime prevalence of approximately 1% which 
leads to enormous economical and social costs (20 billion € in 2005 in EU) [1]. This is 
due to the fact that the pathophysiology is still unclear and the existing treatments 
are largely ineffective in targeting the pronounced cognitive and physiological 
dysfunctions. 
One critical factor in potentially improving the outcome would be the identification 
of individuals at ultra high-risk (UHR) for the development of First Episode Psychosis 
(FEP) to allow the possibility to intervene prior to the full manifestation of the 
syndrome [2]. Evidence suggests that FEP is preceded by a prodromal early phase 
involving attenuated subthreshold, psychotic symptoms of up to 5 years [3] which 
are associated with a reduction in brain tissue and cognitive deficits [4]. Accordingly, 
one central goal of current research is the characterization of the underlying 
pathophysiological processes in UHR-participants and the development of 
biomarkers, which would allow prediction of the illness-trajectory, as well as the 
identification of psychological and neurobiological mechanisms which confer 
resilience in at-risk individuals. 
The search for biomarkers for early diagnosis identification of psychosis has focused 
on brain imaging techniques with an excellent spatial but limited temporal resolution 
for neural events, such as functional and anatomical magnetic resonance imaging 
(fMRI) [4]. This issue may be important because normal brain functioning and the 
associated cognitive processes are fundamentally depended upon fast (millisecond) 
and transient synchronization of neural oscillations [5] which are ideally captured 
with Electro/Magnetoencephalography (EEG/MEG) approaches. 
Emerging evidence suggests that ScZ is associated with aberrant neural oscillations 
and their synchronization (neural synchrony), in particular at gamma-band 
frequencies (30-200 Hz), during a wide range of cognitive and perceptual processes, 
including working memory [6]  and visual perception [7]. Brain oscillations have been 
shown to occur during normal brain functioning and are closely linked to the ability 
to perceive, memorize and attend to information. Thus, it appears that brain 
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oscillations could be a key to understanding the prediction of those who develop FEP 
and ScZ. 
Importantly, the impairments in neural synchrony are ideally suited for translational 
research because of evidence linking gamma-band oscillations during normal brain 
functioning to the integrity of GABAergic interneurons [8] and glutamatergic 
neurotransmission [9]. Supporting this hypothesis, the diagnosis of ScZ is associated 
with pronounced abnormalities in levels of GABA and Glutamate measured by 
magnetic resonance spectroscopy (MRS) [10]. 
 
Rationale 
ScZ remains one of the most challenging and urgent problems in science and medical 
research because of the severe disability associated with the disorder and the lack  of 
progress in identifying the underlying causes. One critical factor in potentially 
improving the outcome of ScZ would be the identification of individuals at high-risk 
for the development of the disorder, to allow the possibility to intervene prior to the 
full manifestation of the syndrome. 
In the proposed project, we will employ for the first time a state-of-the-art MEG 
approach to investigate neural synchrony in UHR-participants for the development of 
FEP with the aim of improving the prediction of progression. Despite the 
fundamental role of neural oscillations and their synchronization in the 
pathophysiology of ScZ [11], neural synchrony in UHR- participants has not been 
systematically explored. In addition, we will employ MRS to establish links between 
aberrant GABAergic and Glutamategic neurotransmission and neural synchrony 
parameters in prodromal ScZ. 
 
In essence, the impact of this research will target the physiological and psychological 
mechanisms that predispose and protect individuals from developing psychosis. 
Firstly, we will gain an unprecedented amount of insight into the contribution of 
neural synchrony to the onset and cognitive dysfunctions amongst young people at 
risk of FEP through the reconstruction of large-scale oscillatory networks during 
resting-state and cognitive  processes. This will give rise to new explanatory theories 
and specific models of pathophysiological processes. Secondly, we will develop a 
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prognostic model based on MEG- data that will allow the early detection of 
participants with an elevated risk for the development of FEP which can be used for 
the prediction of the illness course, thus leading eventually to more targeted 
therapeutic approaches and possibly reducing the incidence of FEP. Thirdly, we will 
establish links with core dysfunctions in GABAergic and Glutamatergic 
neurotransmission through correlations with MRS-data which will be crucial for links 
with translational research and the development of novel, evidence-based 
interventions for UHR- participants. 
In addition to UHR-participants, we expect that we will also detect participants who 
are already experiencing FEP-symptoms. Recruitment of this group will allow 
comparisons of brain activity patterns with UHR-participants. Finally, we will identify 
the contribution of core psychological variables, such as trauma, interpersonal 
functioning and affect regulation, towards transition to FEP which will could 
potentially lead to an improved understanding of onset-mechanisms of psychosis. 
Furthermore, we will carry out comprehensive psychiatric and psychological 
assessments which will provide clinically-relevant information which could be 
potentially be relevant for treatment planning in FEP- and UHR-participants. 
 





1.2 Prior experience of intervention in ScZ/UHR-participants 
 
Previous work by the Chief Investigator (CI) with MEG has demonstrated pronounced 
impairments in high-frequency oscillations in chronically, medicated ScZ patients [12] 
as well as in medication-naïve FEP patients [13]. With a particular relevance for the 
present proposal, fluctuations in 60-120 Hz power could be used to differentiate 
participants with FEP from controls with a discrimination accuracy of 90 % through a 
linear classifier (Figure 1). 
Recruitment of UHR-participants will be supported by Prof. Andrew Gumley, 
Professor of Psychological Therapy, University of Glasgow and NHS Greater Glasgow 
& Clyde. In a previous study funded by the Medical Research Council (MRC), a 
sample of 61 participants meeting UHR-criteria was obtained over a 30-months 
period from the clinical services associated with NHS Greater Glasgow and Clyde, 
demonstrating the feasibility of recruitment [14]. Much was learned regarding the 
pathways into care for this population and this learning will be applied in devising 
recruitment strategies for the proposed project. 
In addition to NHS-Greater Glasgow and Clyde, recruitment of UHR-participants will 
also involve NHS Lothian and the Departments of Psychiatry and Clinical Psychology 
at Edinburgh University. Recruitment will be supported by Matthias Schwannauer 
who is Professor of Clinical Psychology and Head of Clinical & Health Psychology at 
the University of Edinburgh. He is also Consultant Clinical Psychologist at the Early 
Psychosis Support Service in NH Lothian. Professor Stephen Lawrie is Head of the 
Division of Psychiatry in Edinburgh and Director of the Scottish Mental Health 
Research Network. He supervised the MRC funded structural and functional MRI 
components of the Edinburgh High Risk Study. 
 
 
1.3 Study hypothesis 
1) We expect significant impairment in neural synchrony parameters in 
UHR-participants as well as in the FEP-group 
2) Impairments in neural synchrony will be significantly more 
pronounced in those UHR- participants who will make a transition to FEP. 
3) We expect increased GABA/Glutamate levels as assessed through 
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MRS-measurements in UHR- and FEP groups 
4) In addition, UHR- and FEP groups will be characterized by reduced 
gray-matter volume in cortical and subcortical regions as well as reduced 
organization and volume of white-matter 
5) We expect significant correlations between impaired neural 
synchrony parameters, altered GABA/Glutamate levels and anatomical variables 
(MRI, DTI) 
6) We will explore correlations with psychological measures of 
attachment, affect regulation and trauma in order to inform the developing 




The neuroimaging-measurements employed (MEG, MR) are safe and non-invasive 
techniques which have no known risks or side effects. Participants will be carefully 
screened at study entry whether they fulfil exclusion criteria, such as metal implants, 
for participating in neuroimaging experiment (see MR-Checklist). A mental health 
research nurse (RN) will attend all MEG- and MR-measurements of participants 
meeting UHR/FEP-criteria. If a participant becomes distressed during an assessment, 
the measurement will be discontinued. 
 
2. STUDY OBJECTIVES 
 
1) The recruitment of a large sample 100 UHR-participants and 50 
healthy controls over a 4- year period as well as a follow-up to detect transition to 
FEP in the UHR-group 
2) To recruit a sample of n = 25 FEP-participants 
2) MEG-measurements during resting-state and task-related activity in 
combination with a novel methodological approach to comprehensively characterize 
neural synchrony in UHR-and participants and FEP 
3) To establish links between aberrant neural synchrony parameters 
and proton MRS measured GABA/Glutamatergic signalling
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4) To identify the relationships between MEG-parameters and 
cognitive dysfunctions in UHR- participants and FEP 
5) To develop a MEG biomarker for predicting transition to FEP 
6) To identify the contributions of attachment, affect regulation and 
trauma for transition to FEP 
 
This study aims to comprehensively characterize neural circuit dysfunctions in UHR- 
participants using a multi-modal imaging approach and their relationship to core 
psychological variables. Specifically, we will investigate patterns of neural oscillations 
in MEG-data that shall lead to a prognostic index to allow early detection of 
participants with an elevated risk for the development of FEP 
 
 
 Primary Endpoint 
o Neural Oscillations in MEG-Data 
 
 Secondary endpoints 
o MRS measurements of GABA and Glutamate levels 
 
o fMRI-resting state activity 
 
o Conversion to Psychosis 
 
o Neuropsychological functioning 
 
o Social and Role Functioning 
 




3. STUDY DESIGN 
 
The study will be a longitudinal cohort design in UHR-participants and FEP using 
neuroimaging to investigate brain activity in young people at UHR. The YouR-Study 
will be performed according to the Research Governance Framework for Health and 
Community Care (Second edition, 2006). 
 
 
3.1 Study Population 
 
We aim to recruit up to 100 participants meeting UHR-criteria (see Table 1, Appendix 
A) and we expect to identify from this participant group an additional n = 25 
participants who meet criteria for FEP over a four-year period. 50 controls will also 
be recruited. The recruitment of the UHR- and FEP-groups will involve NHS-patients 
services in NHS Greater Glasgow and Clyde, NHS Lothian, student counselling 
services, and the general population (see Figure 2). 
 
 





3.2 Inclusion criteria (UHR) 
 Written informed consent 
 Male or non-pregnant female ≥16 years of age 
 UHR-criteria according to CAARMS/SIPS or SPI-A 
 normal to corrected vision 
 
3.3 Exclusion criteria (UHR) 
 An existing neurological disorder 
 > 35 years of age 
 Metal implants in body parts 
 Pregnancy 
 suicidal ideation 
 
3.4 Inclusion criteria (FEP) 
 Written informed consent 
 Male or non-pregnant female ≥16 years of age 
 Diagnosis of FEP (DSM-IV 295.0) 
 normal to corrected vision 
 
 
3.5 Exclusion criteria (FEP) 
 An existing neurological disorder 
 > 35 years of age 
 Metal implants in body parts 
 Pregnancy 
 suicidal ideation 
 
 
3.6 Inclusion criteria (controls) 
 Written informed consent 
 Male or non-pregnant female ≥16 years of age 
 normal to corrected vision 
 
3.7 Exclusion criteria (controls) 
 An existing neurological disorder
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 > 35 years of age 
 Metal implants in body parts 
 Pregnancy 
 1st degree relative with a diagnosis of ScZ 
 suicidal ideation 
 
 
3.7 Identification of participants and consent 
 
 
The YouR-study comprises of 2 phases: initial screening and a further 
assessment phases. Consent will be taken following the initial screening 
phase for those meeting the initial screening criteria. Only those 
participants that are confirmed to be UHR or FEP will be invited for 
further neuroimaging and psychological assessments. 
 
General population: We will recruit potential participants from the 
general population through a website and flyers (see Attachment). 
Informed consent for the 1st screening stage will be obtained online 
after the purposes and aims of the screening are explained. 
 
NHS-Patients Greater Glasgow and Clyde and NHS-Lothian: We will 
develop close relationships with psychiatrists, primary care and 
secondary mental health services including ESTEEM First Episode 
Psychosis Service (Glasgow), the Early Psychosis Support Service 
(Lothian), Community Mental Health Teams (CMHTs), Primary Care 
Mental Health Teams (PCMHTs), Clinical Psychology Services, 
Community Adolescent Mental Health Services (CAMHS), and non-
statutory (third sector) mental health services. 
Potential participants will be initially informed of the study by a 
member of their direct care team and can then either obtain 
information through leaflets or will be approached through a member 
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of the research team once the potential participant has provided verbal 
consent that their contact details can be shared. A member of the 
research team will then explain the purpose of the study. Following 
this, informed consent will either be obtained on-site after a period of 
24 hrs or a participant can register online for the study. 
 
Edinburgh High-Risk Data base: Participants from the Edinburgh High-
Risk Study (EHRS) will be approached. The EHRS was a longitudinal 
prospective study of the development of ScZ, involving repeated 
clinical, neuropsychological and neuroimaging assessments in almost 
200 individuals at high genetic risk of ScZ. This study was conducted at 
the Department of Psychiatry, University of Edinburgh. The custodian of 
the database study will approach potential participants after contacting 
their GP. 
Recruitment through Universities and Student Counselling Services: We 
will approach University counselling services for potential referrals. A 
referral sheet will allow counsellors to assess the potential 
appropriateness of a referral (Appendix). The student will verbally 
confirm that their details can be passed to the research team. The first 
screening assessment will then either be carried out online or on-site. 
In addition, students will be invited through an email to take part online 
in the study. 
 
3.8 Withdrawal of participants 
 
Participants will be informed that they can withdraw at any point 
during the study and that this will not affect the care or treatment that 
they receive. This will be explained to the participant during the 
informed consent process. Identifiable data collected up to the point of 
withdrawal will be retained, no further data will be collected once the 
participant has withdrawn. 
In addition, participation who have completed the screening 
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questionnaire but who do not fulfill criteria for either UHR-status or 
FEP, will not be invited to participate in phase 2 of the study. The 
ineligible participants will a debrief session with the CI and if required 
will be notified of a referral process to NHS services. 
 
 
4. TRIAL PROCEDURES 
4.1 Study schedule 
The initial screening and psychological assessments for patients 
recruited through NHS Greater Glasgow & Clyde will be conducted at 
the University of Glasgow, University of Edinburgh, or participants 
homes. Neuroimaging assessments for all groups of participants will be 




 Informed consent will be obtained either online through the 
website or on site by a member of the research team. Following 
informed consent, the screening questionnaire will be 
administered (Appendix) and basic demographic information 
will be obtained. If participant score below 6 items on the PQ or 
endorse less than 3 perceptual and cognitive items, the 
participant will not proceed further and the data will be deleted.
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 All participants who fill-out the questionnaire will informed of 
the opportunity to take part in a prize-draw for an I-pad. If the 
participant agrees to entry in the prize-draw, the email-address 
of participants will be stored. 
 
Screening Interview (Visit I) 
 If participants endorse more then 6 items on the PQ or 3 or 
more perceptual/cognitive items, participants will be contacted 
per telephone/email by a member of research team. Basic 
demographic information will be confirmed as well as data 
concerning and suicidality will be obtained. If participants are 
currently suicidal, appropriate referrals will be made and the 
participant will not continue in the study. 
 A first visit will then be scheduled. After informed consent is 
obtained during which the positive scale of the CAARMS/SIPS-
Interview [15, 16] and the COGDIS/COPER items for the SPI-A 
[17] are administered to establish UHR-criteria. In addition, 
information about family history, drug abuse and demographic 
information will be obtained (see Appendix). (Duration 90-120 
Min) 
 
Following the screening stage, participants who have completed the 
screening-questionnaire and screening-interview will be discussed in a 
weekly team-meeting to confirm potential UHR or FEP-criteria. 
 
Debriefing (Visit II) 
 
 All participants who have completed the screening stage will be 
invited for a debrief visit. If participants do not meet criteria for 
UHR or FEP, they will be debriefed about the study and if a 
referral for further psychiatric evaluation and treatment is 
required, appropriate referrals will be made. 
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 Participants who were found to potentially be FEP during phase 
1 (screening) will be referred to the appropriate NHS service 
and if appropriate invited to continue participation in the study 
to Phase 2. 
 Participants who meet UHR criteria will be invited take part in phase 2 
(assessments). 
 





Psychological Assessment I (Visit III) 
The positive scale of the CAARMS/SIPS-Interview [15, 16], the COGDIS/COPER 
items for the SPI-A [17] and M.I.N.I. International Neuropsychiatric Interview 
(M.I.N.I. 6.0) 
[19] as well as the scales for premorbid adjustment and social 




Psychological Assessment III (Visit IV) 
UHR-participants will receive further neuropsychological assessments 
and questionnaires which assess global and social functioning. 
 The neuropsychological assessment consists of the Brief 
Assessment of Cognition in Schizophrenia Battery (BACS) [18] as 
well the following tasks from the University of Pennsylvania 
Computerized Neuropsychological Testing Battery (PennCNP): a) 
Continuous Performance Test b) N-Back Task and c) Emotion 
Identification Task. In addition, the Edinburgh Handedness 
Inventory, the National Adult Reading Test and visual acuity test 
will be administered. 
 Several psychological measures will be used in order to identify 
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mechanisms of change and predictors of outcome. All are brief 
self-report scales, which have good psychometric properties. 
We have successfully used all of these measures in several large 
studies including CBT trials. These include: 
1) The Beliefs About Paranoia Scale (BAPS) 2) The Brief Core Schema Scale 
(BCSS) 
3) The Psychosis Attachment Measure (PAM-SR) 4) Adverse 
childhood experience scale  (ASES) and 5) The Rust Inventory of 





Psychological Assessment I (Visit III) 
 Participants who may have a FEP will receive the SCID and the 
PANSS to establish the likelihood of an existing DSM 295.9 
diagnosis. If this is confirmed, an immediate referral to FEP-
services will be initiated where further diagnostic assessments 






Screening and Psychological Assessment I (Visit I) 
 Informed consent will be obtained and the positive scale of the 
CAARMS/SIPS- Interview [15, 16], the COGDIS/COPER items for 
the SPI-A [17] and M.I.N.I. International Neuropsychiatric 
Interview (M.I.N.I. 6.0) [19] will be administered. In addition, 
the scales for premorbid adjustment and social and functional 
role scales (Cornblatt et al.) will be used as well as a visual 
acuity test. (Duration 90-120 Min) 
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Screening and Psychological Assessment I (Visit II) 
Neuropsychological assessments and questionnaires will be administered during 
Visit II. 
 The neuropsychological assessment consists of the Brief 
Assessment of Cognition in Schizophrenia Battery (BACS) as 
well the following tasks from the University of Pennsylvania 
Computerized Neuropsychological Testing Battery (PennCNP): 
a) Continuous Performance Test b) N-Back Task and c) 
Emotion Identification Task. In addition, the Edinburgh 
Handedness Inventory and the National Adult Reading Test 
will be administered. 
 In addition, the following questionnaires will be administered: 
1) The Beliefs About Paranoia Scale (BAPS) 2) The Brief Core 
Schema Scale (BCSS) 3) The Psychosis Attachment Measure 
(PAM-SR) 4) Adverse childhood experience scale 5) The Rust 
Inventory of Schizotypal Cognitions (RISC) 6) Inventory of 
interpersonal problems – 32 item Version 7) The Significant 
Others Scale and 8) The International Positive and Negative 
Affect Schedule, short-form (I-PANAS-SF) and 9) Social 
Interaction Anxiety Scale (SIAS) (duration: 2 hours) 
 
Neuroimaging for UHR/FEP/Controls 
All participants will receive the same neuroimaging protocol following 
the psychological assessments. For participants in the FEP-group if 
feasible for acutely psychotic patients, the neuroimaging will be 
conducted before or shortly after the initiation of appropriate 
pharmacological treatment. MEG and MR-measurements will be 
conducted at the Centre for Cognitive Neuroimaging (CCNi), University 
of Glasgow. 
 
The MRI- and MEG-protocols consist of the 
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following measurements. MRI: 
a) a resting-state fMRI-measurement 
b) an anatomical scan 
c) a DTI-sequence 
d) a MRS-measurement to obtain information on GABA 
and Glutamate levels Total duration: 60 min 
 
MEG: 
a) Resting-State activity during an eyes-closed and eyes-open 
b) Moving-Grating Task: The task requires participants to fixate a sine-
wave grating which accelerates at an unpredictable moment (Figure 
1a) 
c)  
d) An auditory steady-state (ASS) paradigm: Participants are 
passively presented auditory stimuli consisting of 1500-
msec broadband noise bursts at 5 and 80 Hz (100 trials per 
frequency) presented through plastic tubes at 76 dB sound 
pressure level. On other trials, participants will initiate the 
same auditory stimuli through button press which allows for 
a comparison between auditory responses during a self-
initiated sensory processing vs. passive stimulation. 
e) A variant of a mismatch-negativity (MNN) paradigm which 
involves the manipulation of local and global predictions 
[29] (see Figure 2). In this task, a series of tones are 
presented. When a rare sound is introduced within a 
sequence of repeated frequent sounds, it elicits a novelty 
response in the event- related potential, which has been 
termed the “mismatch negativity” 
(MMN) (Figure 2b). 




Figure 2. a) Moving-Grating task: Participants are required to fixate a 
circular sine-wave grating which accelerates at an unpredictable 
moment and button press whether an acceleration occurs. b) MMN- 
Paradigm: Three auditory stimuli could be presented: local standards 
(a series of five identical tones, denoted xxxxx), local deviants (four 
identical tones followed by a different tone; denoted xxxxY), and 
omissions (four identical tones; denoted xxxx). These stimuli were 
presented in three types of blocks in which one series was presented 
with a high frequency (initially 100%, then 75%) and the other series 
were rare. This design thus separated the local deviancy of the fifth 
sound from the global deviance of the entire sequence and also 
allowed to probe whether the omission effect differed when a 
standard or a deviant tone was expected. 
 
Blood und Urine Samples: In addition, a blood and urine sample may be 
taken prior to the MRI-measurement for potential genetic testing and 
analysis of proteins and metabolites. Blood/urine samples will be 




UHR-participants: Before/after the MRI/MEG-assessments, the 
following questionnaires will be administered 1) Inventory of 
interpersonal problems – 32 item Version 2) The Significant Others 
Scale and 3) The International Positive and Negative Affect Schedule, 
short-form (I- PANAS-SF) and 4) Social Interaction Anxiety Scale 
 
All participants: 1) questionnaire for the assessment of musicality and 
2) the assessment of video gaming 
 
UHR- follow up 
 
 Follow-up interviews via telephone will be conducted every 2-3 
months with UHR- participants. This will include subscales of the 
SIPS/CAARMS as well as the following questionnaires to 
examine stress-levels, interpersonal functioning and affect 
regulation. 1) Inventory of interpersonal problems – 32 item 
Version 2) The Significant Others Scale and 3) The International 
Positive and Negative Affect Schedule, short-form (I-PANAS-SF) 
(Total duration: 90 minutes) 
 In addition to the SIPS/CAARMS and questionnaires, the SCID I 
and II interview and the social and functional role scales will be 




 After a 3-month period initiation of appropriate clinical 
interventions, a follow-up measurement will be scheduled. 
These include MEG-measurements with MEG, 
neuropsychological tests as well as a PANSS-interview. In 
addition, the Edinburgh Handedness Inventory and the 




 a psychophysical assessment to examine elementary 
visual and auditory functions will be scheduled to allow 
for correlations between MEG-parameters and sensory 
processes in controls 
4.2 a second MEG-measurement will be scheduled in which the 
resting-state protocol and MMN-paradigm will be recorded. 
These measurements shall establish the test-retest reliability of 
these parameters. 
 
Study Outcome Measures 
4.2.1 Primary Outcome Measure 
 
The primary outcome measures are MEG-recorded neural oscillations. 
 
 
4.2.2 Secondary Outcome Measure 
 
Secondary outcome measures are: 
a) conversion to psychosis in UHR-subjects 
b) MRS-Spectroscopy 
c) Resting-State fMRI 
d) neuropsychology 
e) trauma-, stress- and affect-levels 
 
 
5. ASSESSMENT OF SAFETY 
 
Following obtaining consent, participants will be screened for 








6.1 Definitions of adverse events 
Adverse Event (AE) – Any untoward medical occurrence in a subject to 
whom a medicinal product has been administered, including 
occurrences which are not necessarily caused by or related to that 
product. 
 
6.2 Serious Adverse Event (SAE) 
Any adverse event or adverse reaction that: 
a. results in death 
b. is life threatening 
c. requires hospitalisation or prolongation of existing hospitalisation 
d. results in persistent or significant disability or incapacity 
e. consists of a congenital anomaly or birth defect 
f. is otherwise considered medically significant by the 
investigator 
g. Important adverse events/ reactions that are not immediately 
life-threatening or do not result in death or hospitalisation 
but may jeopardise the subject or may require intervention to 




Any SAE occurring to a research participant will be reported to the 
Sponsor and the Research Ethics Committee (REC) where in the 
opinion of the Chief Investigator (CI), the event was 
 Related and 
 Unexpected 
 
7. STATISTICS AND DATA ANALYSIS 
 
7.1 Statistical analysis plan 
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The proposed project aims to establish a biomarker for the early 
identification of FEP in UHR- participants. For the analysis of MEG-
signals, advanced statistical methods to estimate task- related effects 
and to control for multiple comparisons will be employed, such as 
cluster- based test statistics, that have been employed by the CI’s 
research group. In addition, we will systematically explore relationships 
between neural synchrony variables (task and resting- state) and 
GABA/Glutamate levels with psychopathological and psychological 
variables in the UHR-group. Specifically, we will identify those MEG 
(sensor, frequency and source-regions) and MRS-parameters with the 
largest effect size and perform information theoretical analysis to 
identify linear and non-linear dependencies. 
 
 
7.2 Software for statistical analysis 
Statistical analysis will be performed in open-software platforms for 
the analysis of MEG-data, such as fieldtrip: 
http://fieldtrip.fcdonders.nl/, and customized, in-house scripts. 
Sample size 
We are confident that the MEG-approach employed in the proposed 
project will yield reliable and robust effects in UHR-participants as well 
as allow the development of a biomarker for prediction of psychosis in 
UHR-participants. Our current research with MEG has demonstrated 
large effect sizes for deficits in high-frequency oscillations in chronically 
medicated ScZ- patients as well as in medication-naïve FE-ScZ patients 
(chronic ScZ: d= 1.26; FE-ScZ d= 1.0) 
[13] [12]. Because of novel and more advanced analyses approaches for 
the proposed project, we will maximise the possibility to detect 
dysfunctions in UHR-participants that will be in the range and above of 
effect sizes currently available for prodromal ScZ-research. 
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Previous studies with a variety of methods, such MR, fMRI as well as 
event-related potentials (ERPs), have demonstrated anatomical and 
physiological impairments in UHR-cohorts with medium to large effect 
sizes compared to healthy participants [1,5,6]. For example, Atkinson et 
al. [19] demonstrated an impairment in mismatch negativity (MMN) in 
UHR-participants vs. controls of d = .75. Given a sample of n = 50 
controls and 100 UHR-participants and an estimated effect size of .75 
for the current study, the power to detect significant differences in 
MEG-parameters between controls and UHR-participants is 97%. 
 
In regards to the ability to distinguish between UHR-participants who 
will convert to  psychosis vs. UHR-participants without transition, 
previous published effect sizes have reported medium [4] but also large 
effect sizes [20] for differences on anatomical and functional 
parameters. For the current study, a conservative, medium effect-size 
of d = .5 for a sample of n = 30 converted UHR-participants vs. n = 70 
non-converted UHR-participants will yield a statistical power to detect 
significant differences between these groups of 82%. The sample of n = 
30 converted UHR-participants is consistent with a meta-analysis on 
conversion rates in UHR-participants over a two year period [21]. 
Should UHR-participants be lost in the follow-up period, we will recruit 
additional participants during the course of the project. 
 
 
8. STUDY CLOSURE / DEFINITION OF END OF TRIAL 
 
The study will end when the steering committee agrees that one or 
more of the following situations applies: 
i. The planned sample size has been achieved; 
ii. There is insufficient funding to support further 
recruitment, and no reasonable prospect of additional 
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support being obtained; 




9. DATA HANDLING 
 
9.1 Case Report Forms / Electronic Data Record 
All data and paper questionnaires will be anonymized with a unique 
identifier and stored securely in locked filing cabinets and secure, 
password protected servers. Appropriate access controls will be in 
place to ensure that access to confidential research information is 
restricted to authorised members of the research team. Neuroimaging-
data will be archived on servers of the CCNi which are passport 
protected. Access will be chiefly administered through the CI, to 
members of the research team. 
 
9.2 Record Retention 
Neuroimaging as well as clinical data will be retained at the CCNi in 
secure serves and file- cabinets for a minimum of 5 years. 
 
10. STUDY MONITORING/AUDITING 
 
Study site file will be provided to research team by Sponsor. Sponsor 
will perform study set- up visit and study may be selected randomly 
for audit from Research & Development (R&D) database.
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11. PROTOCOL AMENDMENTS 
 
Any change in the study protocol will require an amendment. 
Any proposed protocol amendments will be initiated by the CI 
following discussion with the Sponsor and amendment forms 
will be submitted to the REC and Research and Development 
(R&D). The CI will liaise with Sponsor to determine whether an 
amendment is non-substantial or substantial. All amended 
versions of the protocol will be signed by the CI and Sponsor 
representative.  Before the amended protocol can be 
implemented favourable opinion/approval must be sought 




11.1 Ethical conduct of the study 
The study will be carried out in accordance with the World 
Medical Association Declaration of Helsinki (1964) and its 
revisions (Tokyo [1975], Venice [1983], Hong Kong [1989], 
South 
Africa [1996] and Edinburgh [2000]). 
Favourable ethical opinion will be sought from an appropriate 
REC before patients are  entered into this clinical trial. Patients 
will only be allowed to enter the study once either they have 
provided written informed consent. 
 
The CI will be responsible for updating the REC of any new information 
related to the study. 
 
11.2 Informed consent 
 
 
Written informed consent should be obtained from each trial 
participant prior to participation in each phase. Consent may 
be provided on-line or at a visit with a member of the research 
team prior to screening phase. Consent will be provided at a 
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visit prior to assessment phase (phase 2). A member of the 
research will explain the exact nature of the study in writing, 
provision of patient information sheet, and verbally. Study 
participants will be informed that they are free to withdraw 
their consent from the study or study treatment at any time. 
 
 
12. INSURANCE AND INDEMNITY 
 
The Youth Mental Mental Health Risk and Resilience Study is 
sponsored by NHS Greater Glasgow & Clyde. The sponsor will 
be liable for negligent harm caused by the design of the trial. 
NHS indemnity is provided under the Clinical Negligence and 
Other Risks Indemnity Scheme (CNORIS). 
 
The NHS has a duty of care to patients treated, whether or not 
the patient is taking part in a clinical trial, and the NHS remains 
liable for clinical negligence and other negligent harm to 
patients under its duty of care. 
 
Participants will attend study visits at CCNi, University of 
Glasgow. Appropriate insurance cover for negligence to 
participants at this non-NHS research site will be provided by 
University of Glasgow. 
FUNDING 
 
The study is supported by a grant from the Medical Research 
Council “Using Magnetoencephalography to Investigate 
Aberrant Neural Synchrony in Prodromal Schizophrenia: A 
Translational Biomarker Approach” (MR/L011689/1 64069/1). 




13. ANNUAL REPORTS 
 
Annual progress reports will be submitted to REC on the 
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anniversary of the ethics favourable opinion. A copy of this 
report will also be sent to the Sponsor. 
 
 
14. DISSEMINATION OF FINDINGS 
 
 
We will organise a study launch conference to develop a 
clinical network for staff across NHS Greater Glasgow & Clyde 
and NHS Lothian. We will enhance engagement with mental 
health services by offering subsequent training in the 
identification of young people at UHR. We will provide mental 
health staff with Continuing Professional Development (CPD) 
certificates. We will apply to be adopted by the Scottish 
Mental Health Research Network in order to enhance 
recruitment and engagement mental health staff and young 
people at UHR. We will periodically organise Knowledge 
Exchange and Impact events to enhance stakeholder 
engagement. We will systematically identify key stakeholders 
including groups who represent the needs and views of young 
people. 
 
The academic community will be reached via its standard ways of 
dissemination at conferences and in high impact journals aiming not only at 
researchers of ScZ, but at the wider academic audience interested clinically 
or generally in neural synchrony and the application of MEG. The wider 
public will be informed in an appropriate manner via internet, radio, 
television, and specific publications in outlets aimed at such an audience. 
Sufferers of ScZ and their relatives will be reached via appropriate 
organisations and charities by providing information for use on their 
websites and the offer to give oral presentations to their members. Finally, 
we will specifically target potential users of our research maximising the 
chances of immediate impact. Via established networks within the Institute 
of Neuroscience and Psychology (INP) we will widely disseminate our 
findings to users in clinics and the pharmaceutical industry using their 
feedback to identify potential attendees for a dedicated workshop to 
disseminate our findings in concentrated form and to identify potential 
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                     Table 1. UHR-criteria 




 Disorganized Speech; or 5–6 on Perceptual Abnormalities 
 2) A Frequency Scale score of 4–6 on the relevant symptom scale 
3) Symptoms are present for less than one week 
4) Symptoms resolve without medication 




A. Subthreshold intensity 
1) A Global Rating Scale score of 3–5 on Unusual Thought Content or 
Non-Bizarre Ideas; or 3–4 on Perceptual Abnormalities; or 4–5 on 
Disorganized Speech 
2) A Frequency Scale score of 3–6 on the relevant symptom scale 
3) Symptoms are present for more than one week 
4) Symptoms occurred during the 
past year B. Subthreshold frequency: 
1) A Global Rating Scale score of 6 on Unusual Thought Content, Non-
Bizarre Ideas, or Disorganized Speech; or 
5–6 on Perceptual Abnormalities 
2) A Frequency Scale score of 3 on the relevant symptom scale 





1) History of psychosis in a first-degree relative or identification of 
Schizotypal Personality Disorder 
2) 30% drop in GAF score from pre-morbid level, sustained for at least one 
month, within the past year or a GAF score of 50 or less for at least the past 
year 









Appendix H Example of the Adverse Childhood Experiences questionnaire 
Adverse Childhood Experiences Study Questionnaires  
 
PT’s Initials: ______ PT’s ID: ___________ Interviewer: _________ Time: _____ 
Date: ________ 
 
1.) Sometimes parents or adults hurt children. While you were growing up, that is 
during your first 18 years of life, how often did a parent, step-parent or other 
adult in your home swear at you, insult you or put you down? 
 
Never                once, twice              sometimes                often                very often 
 
2.) While you were growing up, that is during your first 18 years of life, how often 
did a parent, step-parent or other adult in your home act in a way that made you 
afraid that you might be physically hurt? 
 
Never                once, twice              sometimes                often                very often 
 
3.) While you were growing up, that is during your first 18 years of life, how often 
did a parent, step-parent or other adult in your home actually push, grab, shove, 
slap or throw something at you? 
 
Never                once, twice              sometimes                often                very often 
 
4.) While you were growing up, that is during your first 18 years of life, how often 
did a parent, step-parent or other adult in your home hit you so hard that you had 
marks or were injured? 
 
Never                once, twice              sometimes                often                very often 
 
5.) Some people, while growing up in their first 18 years of life, had a sexual 
experience with an adult or someone at least five years older than themselves. 
These experiences may have involved a relative, family friend, or stranger. During 
the first 18 years of life, did an adult or older relative, family friend, or stranger 
ever touch or fondle your body in a sexual way? 
 
Yes                                                       no 
 
6.) Have you touch their body in a sexual way? 
 
Yes                                                       no 
 
7.) Actually have any type of sexual intercourse (oral, anal, vaginal) with you? 
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Yes                                                       no 
 
 (skip Question 8, if answered “Yes” to question 7) 
 
8.) Attempt to have any type of sexual intercourse (oral, anal, vaginal) with you? 
 
Yes                                                       no 
 
9.) During your first 18 years of life did you ever live with anyone who was a 
problem drinker or alcoholic? 
 
Yes                                                       no 
 
And who was that? ______________________________________ 
 
10.) During your first 18 years of life did you ever live with anyone who used 
street drugs? 
 
Yes                                                       no 
 
And who was that? ______________________________________ 
 
11.) During your first 18 years of life was anyone in your household depressed or 
mentally ill? 
 
Yes                                                       no 
 
And who was that? ______________________________________ 
 
12.) During your first 18 years of life did anyone in your household attempt to 
commit suicide? 
 
Yes                                                       no 
 
And who was that? ______________________________________ 
 
13.) Sometimes physical blows occur between parents. While you were growing 
up in your first 18 years of life, how often did your father (or stepfather) or 
mother’s boyfriend do any of these things to your mother (or stepmother)? Push, 
grab, slap or throw things at her? 
 
Never                once, twice              sometimes                often                very often 
 
14.) Kick, bite, hit her with a fist, or hit her with something hard? 
 
155  
Never                once, twice              sometimes                often                very often 
 
15.) Repeatedly hit her for over at least a few minutes? 
 
Never                once, twice              sometimes                often                very often 
 
16.) Threaten her with a knife or gun, or use a knife or gun to hurt her? 
 
Never                once, twice              sometimes                often                very often 
 
17.) During your first 18 years of life did anyone in your household ever go to 
prison? 
 
Never                once, twice              sometimes                often                very often 
 
And who was that? ______________________________________ 
18.) During your first 18 years of life were your parents ever separated or 
divorced? 
 
Yes                                                       no 
 
 (Note if parents were never together, mark as “Yes”) 
 
19.) While you were growing up, during your first 18 years of life, how true were 
each of the following statements? You didn’t have enough to eat. 
 
Never                once, twice              sometimes                often                very often 
 
20.) You had to wear dirty clothes. 
 
Never                once, twice              sometimes                often                very often 
 
21.) There was someone to take you to the doctor if you needed it. 
 
Never                once, twice              sometimes                often                very often 
 
22.) Your parents were too drunk or high to take care of the family. 
 
Never                once, twice              sometimes                often                very often 
 
23.) You knew there was someone to take care of you and protect you. 
 
Never                once, twice              sometimes                often                very often 
 
And who was that? ______________________________________ 
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24.) There was someone in your family who helped you feel special or important. 
 
Never                once, twice              sometimes                often                very often 
 
And who was that? ______________________________________ 
 
25.) You felt loved. 
 
Never                once, twice              sometimes                often                very often 
 



















Appendix I Demographic variables that were non-significant between group )CHR 
and controls) and levels of ACES (none, low, high) 
 Comparisons 
Age compared across those at high risk 
and controls 
No significant differences emerged 
between high risk sample and controls in 
age, F(1,161), =2.34, p = .128 
Gender compared between those at 
high risk and controls 
  No significant differences in gender, X 2  
= 2.43), p = .120.  
Premorbid IQ compared between 
controls and those at high risk 
No significant differences between 
controls and those at high risk in 
premorbid IQ as derived from the NART 
full scale, F(1,152) = .843, p = .360  
 
Years of education compared between 
levels of ACEs 
No significant differences between level 
of ACES in years of education, F(1,151) = 
.344, p = .709. 
Gender compared across levels of ACEs  
No significant differences between levels 
of ACES in gender, F(1,151) = .654, p = 
.521. 
Medication compared against levels of 
ACEs 
No significant differences between levels 
of ACES in medication, F (1,151) = 1.903, 
p = .153. 
Age Compared between levels of ACEs. No significant differences between level 




Appendix J Checking the parametric assumptions of a two way MANOVA  
Assumption #4 
There should be a linear relationship between the dependent variables for each 
group of the independent variable.  
There was a linear relationship between the dependent variables, as assessed by 
scatterplot. 
Assumption #5 
There should be no multicollinearity  
There was no evidence of multicollinearity, as assessed by Pearson correlation (|r| 
< 0.9). 
Assumption #6 
There should be no univariate or multivariate outliers  
There were no univariate outliers in the data, as assessed by inspection of a boxplot 
for values greater than 1.5 box-lengths from the edge of the box. 
Assumption #7 
There needs to be multivariate normality  
There were no multivariate outliers in the data, as assessed by Mahalanobis 
distance (p > .001). 
Assumption #8 
You should have an adequate sample size 
In order to run a two-way MANOVA, each cell of the design must have at least as 
many cases as there are dependent variables. In this example, there are two 
dependent variables. Therefore, there needs to be two or more cases per cell of the 
design. You can confirm whether this is the case by inspecting the "N" column in 
the Descriptive Statistics table, as highlighted below:  
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Assumption #9 
There should be homogeneity of variance-covariance matrices  
 
Assumption #10 





















There was homogeneity of variances, as assessed by Levene's test for equality of 
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